Exhibit 17(a)


 Exhibit 10.17(a) 

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 
 LOAN AND SECURITY AGREEMENT 

THIS LOAN AND SECURITY AGREEMENT is made and dated as of December 16, 2013 and is entered into by and between ViewRay Incorporated, a
Delaware corporation, and each of its subsidiaries (hereinafter collectively referred to as the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred
to as “Lender”) and HERCULES TECHNOLOGY GROWTH CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent for itself and the Lender (in such capacity, the “Agent”). 

RECITALS 
 A. Borrower has
requested Lender to make available to Borrower a loan in an aggregate principal amount of up to Fifteen Million Dollars ($15,000,000) (the “Term Loan”); and 

B. Lender is willing to make the Term Loan on the terms and conditions set forth in this Agreement. 

AGREEMENT 
 NOW,
THEREFORE, Borrower, Agent and Lender agree as follows: 
 SECTION 1. DEFINITIONS AND RULES OF CONSTRUCTION 

1.1 Unless otherwise defined herein, the following capitalized terms shall have the following meanings: 

“Account Control Agreement(s)” means any agreement entered into by and among the Agent, Borrower and a third party Bank or other
institution (including a Securities Intermediary) in which Borrower maintains a Deposit Account or an account holding Investment Property and which grants Agent a perfected first priority security interest in the subject account or accounts. 

“ACH Authorization” means the ACH Debit Authorization Agreement in substantially the form of Exhibit H. 

“Advance(s)” means a Term Loan Advance. 

“Advance Date” means the funding date of any Advance. 

“Advance Request” means a request for an Advance submitted by Borrower to Agent in substantially the form of Exhibit A. 

“Affiliate” means, with respect to any Person, another Person that directly, or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with the Person specified. 






 “Agent” has the meaning given to it in the preamble to this Agreement. 

“Agreement” means this Loan and Security Agreement, as amended from time to time. 

“Amortization Date” means January 1, 2015; provided however, if the Interest Only Extension Conditions are satisfied, then such
date shall be automatically extended to July 1, 2015. 
 “Assignee” has the meaning given to it in Section 11.13. 

“Borrower Products” means all products, software, service offerings, technical data or technology currently being designed,
manufactured or sold by Borrower or which Borrower intends to sell, license, or distribute in the future including any products or service offerings under development, collectively, together with all products, software, service offerings, technical
data or technology that have been sold, licensed or distributed by Borrower since its incorporation. 
 “Business Day” means any
day other than Saturday, Sunday and any other day on which banking institutions in the State of California are closed for business. 

“Cash” means all cash and liquid funds. 

“Cash Interest Rate” means for any day a per annum rate of interest equal to the greater of either (i) the prime rate as
reported in The Wall Street Journal plus 7.00%, and (ii) 10.25%. 
 “Change in Control” means any (i) reorganization,
recapitalization, consolidation, merger, sale or exchange of outstanding shares (or similar transaction or series of related transactions) of Borrower in which the holders of Borrower outstanding shares immediately before consummation of such
transaction or series of related transactions do not, immediately after consummation of such transaction or series of related transactions, retain shares representing more than fifty percent (50%) of the voting power of the surviving entity of
such transaction or series of related transactions (or the parent of such surviving entity if such surviving entity is wholly owned by such parent), in each case without regard to whether Borrower is the surviving entity; provided that any sale or
other disposition of the shares of Borrower after the Closing Date among the four (4) larger holders of such interests on the Closing Date shall not constitute a Change in Control, or (ii) sale or issuance by Borrower of new shares of
Preferred Stock of Borrower to investors, none of whom are current investors in Borrower, and such new shares of Preferred Stock are senior to all existing Preferred Stock and Common Stock with respect to liquidation preferences, and the aggregate
liquidation preference of the new shares of Preferred Stock is more than fifty percent (50%) of the aggregate liquidation preference of all shares of Preferred Stock of Borrower; provided, however, an Initial Public Offering shall not
constitute a Change in Control. 
 “Claims” has the meaning given to it in Section 11.10. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 “Closing Date” means the date of this Agreement. 

“Collateral” means the property described in Section 3. 

“Confidential Information” has the meaning given to it in Section 11.12. 

“Contingent Obligation” means, as applied to any Person, any direct or indirect liability, contingent or otherwise, of that Person
with respect to (i) any Indebtedness, lease, dividend, letter of credit or other obligation of another, which is directly or indirectly guaranteed, endorsed, co-made or discounted or sold with recourse by
such Person, or in respect of which such Person is otherwise directly or indirectly liable; (ii) any obligations with respect to undrawn letters of credit, corporate credit cards or merchant services issued for the account of such Person; and
(iii) all obligations arising under any interest rate, currency or commodity swap agreement, interest rate cap agreement, interest rate collar agreement, or other agreement or arrangement designated to protect such Person against fluctuation in
interest rates, currency exchange rates or commodity prices; provided, however, that the term “Contingent Obligation” shall not include endorsements for collection or deposit in the ordinary course of business. The amount of any Contingent
Obligation shall be deemed to be an amount equal to the stated or determined amount of the primary obligation in respect of which such Contingent Obligation is made or, if not stated or determinable, the maximum reasonably anticipated liability in
respect thereof as determined by such Person in good faith; provided, however, that such amount shall not in any event exceed the maximum amount of the obligations under the guarantee or other support arrangement. 

“Copyright License” means any written agreement granting any right to use any Copyright or Copyright registration, now owned or
hereafter acquired by Borrower or in which Borrower now holds or hereafter acquires any interest. 
 “Copyrights” means all
copyrights, whether registered or unregistered, held pursuant to the laws of the United States, any State thereof, or of any other country. 

“Deposit Accounts” means any “deposit accounts,” as such term is defined in the UCC, and includes any checking account,
savings account, or certificate of deposit. 
 “Domestic Subsidiary” means any Subsidiary that is not a Foreign Subsidiary. 

“Eligible Assignee” means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or
otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its activities. 
 “ERISA”
means the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated thereunder. 
 “Event of
Default” has the meaning given to it in Section 9. 
 “Facility Charge” means one percent (1%) of the Maximum Term
Loan Amount. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 “Financial Statements” has the meaning given to it in Section 7.1. 

“Foreign Subsidiary” means any Subsidiary other than a Subsidiary organized under the laws of any state within the United States.

 “GAAP” means generally accepted accounting principles in the United States of America, as in effect from time to time. 

“Indebtedness” means indebtedness of any kind, including (a) all indebtedness for borrowed money or the deferred purchase price
of property or services (excluding trade credit entered into in the ordinary course of business and not past due for more than 61 days), including reimbursement and other obligations with respect to surety bonds and letters of credit,
(b) all obligations evidenced by notes, bonds, debentures or similar instruments, (c) all capital lease obligations, and (d) all Contingent Obligations. 

“Initial Public Offering” means the initial firm commitment underwritten offering of Borrower’s common stock pursuant to a
registration statement under the Securities Act of 1933 filed with and declared effective by the Securities and Exchange Commission. 

“Intellectual Property” means all of Borrower’s Copyrights; Trademarks; Patents; Licenses; trade secrets and inventions; mask
works; Borrower’s applications therefor and reissues, extensions, or renewals thereof; and Borrower’s goodwill associated with any of the foregoing, together with Borrower’s rights to sue for past, present and future infringement of
Intellectual Property. 
 “Interest Only Extension Conditions” shall mean satisfaction of each of the following events:
(a) no default or Event of Default shall have occurred and be continuing; and (b) delivery by Borrower to Lender of evidence satisfactory to Lender of the placement of six (6) Borrower’s systems by December 31, 2014 and
receipt of the purchase price thereof by Borrower within 6 months of delivery pursuant to invoicing in the ordinary course of business. 

“Investment” means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any
Person, or any loan, advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person. 

“Joinder Agreements” means for each Subsidiary, a completed and executed Joinder Agreement in substantially the form attached hereto
as Exhibit G. 
 “Lender” has the meaning given to it in the preamble to this Agreement. 

“License” means any Copyright License, Patent License, Trademark License or other license of rights or interests. 

“Lien” means any mortgage, deed of trust, pledge, hypothecation, assignment for security, security interest, encumbrance, levy, lien
or charge of any kind, whether voluntarily incurred or arising by operation of law or otherwise, against any property, any conditional sale or other title retention agreement, and any lease in the nature of a security interest. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 “Loan” means the Advances made under this Agreement. 

“Loan Documents” means this Agreement, the Notes (if any), the ACH Authorization, the Account Control Agreements, the Joinder
Agreements, all UCC Financing Statements, the Warrant, and any other documents executed in connection with the Secured Obligations or the transactions contemplated hereby, as the same may from time to time be amended, modified, supplemented or
restated. 
 “Magnet Collateral” means the collateral pledged to the County of Cuyahoga, Ohio, as the secured party, as described
on the Closing Date on Schedule 1.2 attached hereto and made a part hereof. 
 “Material Adverse Effect” means a material
adverse effect upon: (i) the business, operations, properties, assets or financial condition of Borrower; or (ii) the ability of Borrower to perform the Secured Obligations in accordance with the terms of the Loan Documents, or the ability
of Agent or Lender to enforce any of its rights or remedies with respect to the Secured Obligations; or (iii) the Collateral or Agent’s Liens on the Collateral or the priority of such Liens. 

“Maximum Term Loan Amount” means Fifteen and No/100 Dollars ($15,000,000). 

“Maximum Rate” shall have the meaning assigned to such term in Section 2.3. 

“Note(s)” means a Term Note. 

“Patent License” means any written agreement granting any right with respect to any invention on which a Patent is in existence or a
Patent application is pending, in which agreement Borrower now holds or hereafter acquires any interest. 
 “Patents” means all
letters patent of, or rights corresponding thereto, in the United States or in any other country, all registrations and recordings thereof, and all applications for letters patent of, or rights corresponding thereto, in the United States or any
other country. 
 “Permitted Indebtedness” means: (i) Indebtedness of Borrower in favor of Lender or Agent arising under this
Agreement or any other Loan Document; (ii) Indebtedness existing on the Closing Date which is disclosed in Schedule 1A; (iii) Indebtedness of up to $1,000,000 outstanding at any time secured by a Lien described in clause (vii) of
the defined term “Permitted Liens,” provided such Indebtedness does not exceed the lesser of the cost or fair market value of the Equipment financed with such Indebtedness; (iv) Indebtedness to trade creditors incurred in the ordinary
course of business, including Indebtedness incurred in the ordinary course of business with corporate credit cards; (v) Indebtedness that also constitutes a Permitted Investment; (vi) Subordinated Indebtedness; (vii) reimbursement
obligations in connection with letters of credit that are secured by cash or cash equivalents and issued on behalf of the Borrower 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
or a Subsidiary thereof in an amount not to exceed $200,000 at any time outstanding, (viii) guarantees provided by Borrower in respect and to the extent of Indebtedness otherwise
constituting Permitted Indebtedness, (ix) Indebtedness arising from any judgment, order, decree or award not constituting and Event of Default under Section 9.6, (x) other Indebtedness in an amount not to exceed $500,000 at any time
outstanding, and (xi) extensions, refinancings and renewals of any items of Permitted Indebtedness, provided that the principal amount is not increased or the terms modified to impose materially more burdensome terms upon Borrower or its
Subsidiary, as the case may be. 
 “Permitted Investment” means: (i) Investments existing on the Closing Date which are
disclosed in Schedule 1B; (ii) (a) marketable direct obligations issued or unconditionally guaranteed by the United States of America or any agency or any State thereof maturing within one year from the date of acquisition thereof,
(b) commercial paper maturing no more than one year from the date of creation thereof and currently having a rating of at least A-2 or P-2 from either
Standard & Poor’s Corporation or Moody’s Investors Service, (c) certificates of deposit issued by any bank with assets of at least $500,000,000 maturing no more than one year from the date of investment therein,
(d) money market accounts and (e) Cash; (iii) repurchases of stock from former employees, directors, or consultants of Borrower in an aggregate amount not to exceed $250,000 in any fiscal year, provided that no Event of Default has
occurred, is continuing or would exist after giving effect to such repurchase; (iv) Investments accepted in connection with Permitted Transfers; (v) Investments (including debt obligations) received in connection with the bankruptcy or
reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of Borrower’s business; (vi) Investments consisting of notes receivable
of, or prepaid royalties and other credit extensions, to customers and suppliers who are not affiliates, in the ordinary course of business, provided that this subparagraph (vi) shall not apply to Investments of Borrower in any Subsidiary;
(vii) Investments consisting of loans not involving the net transfer on a substantially contemporaneous basis of cash proceeds to employees, officers or directors relating to the purchase of capital stock of Borrower pursuant to employee stock
purchase plans or other similar agreements approved by Borrower’s Board of Directors; (viii) Investments consisting of travel advances in the ordinary course of business; (ix) Investments in newly-formed Domestic Subsidiaries,
provided that each such Domestic Subsidiary enters into a Joinder Agreement promptly after its formation by Borrower and execute such other documents as shall be reasonably requested by Agent; (x) Investments in Foreign Subsidiaries approved in
advance in writing by Agent; (xi) joint ventures or strategic alliances in the ordinary course of Borrower’s business consisting of the nonexclusive licensing of technology, the development of technology or the providing of technical
support, provided that any cash Investments by Borrower do not exceed $100,000 in the aggregate in any fiscal year; and (xii) additional Investments that do not exceed $500,000 in the aggregate. 

“Permitted Liens” means any and all of the following: (i) Liens in favor of Agent or Lender; (ii) Liens existing on the
Closing Date which are disclosed in Schedule 1C; (iii) Liens for taxes, fees, assessments or other governmental charges or levies, either not delinquent or being contested in good faith by appropriate proceedings; provided, that Borrower
maintains adequate reserves therefor in accordance with GAAP (if so required); (iv) Liens securing claims or demands of materialmen, artisans, mechanics, carriers, warehousemen, landlords and other


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
like Persons arising in the ordinary course of Borrower’s business and imposed without action of such parties; provided, that the payment thereof is not overdue or such Liens, in the
aggregate, do not materially impair the use thereof in the operation of the business of Borrower; (v) Liens arising from judgments, decrees or attachments in circumstances which do not constitute an Event of Default hereunder; (vi) Liens
incurred in the ordinary course of business in connection with deposits under worker’s compensation, unemployment insurance, social security and other similar laws, or to secure the performance of bids, tenders or contracts (other than for the
repayment of borrowed money) or to secure indemnity, performance or other similar bonds for the performance of bids, tenders or contracts (other than for the repayment of borrowed money) or to secure statutory obligations (other than Liens arising
under ERISA or environmental Liens) or surety or appeal bonds, or to secure indemnity, performance or other similar bonds; (vii) Liens constituting purchase money Liens and Liens in connection with capital leases securing Indebtedness permitted
in clause (iii) of “Permitted Indebtedness”; (viii) Liens incurred in connection with Subordinated Indebtedness; (ix) leasehold interests in leases or subleases and licenses granted in the ordinary course of business and not
interfering in any material respect with the business of the licensor; (x) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of custom duties that are promptly paid on or before the date they become
due; (xi) Liens on insurance proceeds securing the payment of financed insurance premiums that are not overdue (provided that such Liens extend only to such insurance proceeds and not to any other property or assets); (xii) statutory and
common law rights of set-off and other similar rights as to deposits of Cash and securities in favor of banks, other depository institutions and brokerage firms; (xiii) easements, zoning restrictions, rights-of-way and similar encumbrances on
real property imposed by law or arising in the ordinary course of business so long as they do not materially impair the value or marketability of the related property; (xiv) Liens on Cash or cash equivalents securing obligations permitted under
clause (vii) of the definition of Permitted Indebtedness; (xv) the interests of lessors under operating leases and non-exclusive licensors under Licenses; (xvi) non-exclusive licenses of Intellectual Property rights in the ordinary
course of business; (xvii) other Liens which do not secure Indebtedness for borrowed money or letters of credit and as to which the aggregate amount of the obligations secured thereby does not exceed $500,000; and (viii) Liens incurred in
connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clauses (i) through (xi) above; provided, that any extension, renewal or replacement Lien shall be limited to the property
encumbered by the existing Lien and the principal amount of the Indebtedness being extended, renewed or refinanced (as may have been reduced by any payment thereon) does not increase. 

“Permitted Transfers” means (i) sales of Inventory in the ordinary course of business, (ii)(A) non-exclusive licenses and
similar arrangements for the use of Intellectual Property in the ordinary course of business and (B) licenses that could not result in a legal transfer of title of the licensed property but that may be exclusive in respects other than territory
and that may be exclusive as to territory only as to discreet geographical areas outside of the United States in the ordinary course of business, (iii) dispositions of worn-out, obsolete or surplus Equipment or other capital assets at fair
market value in the ordinary course of business, (iv) the leasing or subleasing of assets of Borrower in the ordinary course of business, (v) the sale, discount or write-off of past due or impaired accounts receivable for collection
purposes (but not for factoring, securitization or other financing purposes); (vi) any involuntary loss, 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
damage or destruction of property; (vii) any involuntary condemnation, seizure or taking, by exercise of the power of eminent domain or otherwise, or confiscation or requisition of use of
property; and (viii) other Transfers of assets having a fair market value of not more than $500,000 in the aggregate in any fiscal year. 

“Person” means any individual, sole proprietorship, partnership, joint venture, trust, unincorporated organization, association,
corporation, limited liability company, institution, other entity or government. 
 “PIK Rate” means 1.50% per annum. 

“Preferred Stock” means at any given time any equity security issued by Borrower that has any rights, preferences or privileges
senior to Borrower’s common stock. 
 “Prepayment Charge” shall have the meaning assigned to such term in Section 2.5.

 “Receivables” means (i) all of Borrower’s Accounts, Instruments, Documents, Chattel Paper, Supporting Obligations,
letters of credit, proceeds of any letter of credit, and Letter of Credit Rights, and (ii) all customer lists, software, and business records related thereto. 

“Required Lenders” means, at any time, the holders of more than 50% of the aggregate unpaid principal amount of the Term Loans then
outstanding; provided that any affiliate of a Lender which holds any portion of the Term Loan shall be deemed to have voted with such Lender with respect to any matter hereunder. 

“SBA” shall have the meaning assigned to such term in Section 7.16. 

“SBIC” shall have the meaning assigned to such term in Section 7.16. 

“SBIC Act” shall have the meaning assigned to such term in Section 7.16. 

“Secured Obligations” means Borrower’s obligations under this Agreement and any Loan Document, including any obligation to pay
any amount now owing or later arising. 
 “Subordinated Indebtedness” means Indebtedness subordinated to the Secured Obligations
in amounts and on terms and conditions reasonably satisfactory to Agent. 
 “Subsequent Financing” means the closing of the next
institutional private equity financing which becomes effective after the Closing Date and results in aggregate proceeds to Borrower of at least $5,000,000. 

“Subsidiary” means an entity, whether corporate, partnership, limited liability company, joint venture or otherwise, in which
Borrower owns or controls 50% or more of the outstanding voting securities, including each entity listed on Schedule 1 hereto. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 “Term Commitment” means as to any Lender, the obligation of such Lender, if any, to
make a Term Loan Advance to the Borrower in a principal amount not to exceed the amount set forth under the heading “Term Commitment” opposite such Lender’s name on Schedule 1.1. 

“Term Loan Advance” means any Term Loan funds advanced under this Agreement. 

“Term Loan Maturity Date” means June 1, 2017. 

“Term Note” means a Promissory Note in substantially the form of Exhibit B. 

“Trademark License” means any written agreement granting any right to use any Trademark or Trademark registration, now owned or
hereafter acquired by Borrower or in which Borrower now holds or hereafter acquires any interest. 
 “Trademarks” means all
trademarks (registered, common law or otherwise) and any applications in connection therewith, including registrations, recordings and applications in the United States Patent and Trademark Office or in any similar office or agency of the United
States, any State thereof or any other country or any political subdivision thereof. 
 “UCC” means the Uniform Commercial Code as
the same is, from time to time, in effect in the State of California; provided, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of, or remedies with respect to, Agent’s Lien
on any Collateral is governed by the Uniform Commercial Code as the same is, from time to time, in effect in a jurisdiction other than the State of California, then the term “UCC” shall mean the Uniform Commercial Code as in effect, from
time to time, in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority or remedies and for purposes of definitions related to such provisions. 

“Warrant” means any warrant entered into in connection with the Loan, as may be amended, restated or modified from time to time.

 Unless otherwise specified, all references in this Agreement or any Annex or Schedule hereto to a “Section,”
“subsection,” “Exhibit,” “Annex,” or “Schedule” shall refer to the corresponding Section, subsection, Exhibit, Annex, or Schedule in or to this Agreement. Unless otherwise specifically provided herein, any
accounting term used in this Agreement or the other Loan Documents shall have the meaning customarily given such term in accordance with GAAP, and all financial computations hereunder shall be computed in accordance with GAAP, consistently applied.
Unless otherwise defined herein or in the other Loan Documents, terms that are used herein or in the other Loan Documents and defined in the UCC shall have the meanings given to them in the UCC. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SECTION 2. THE LOAN 

2.1 Term Loan. 

(a) Advances. Subject to the terms and conditions of this Agreement, Lender will severally (and not jointly) make in an amount
not to exceed its respective Term Commitment, and Borrower agrees to draw, a Term Loan Advance of $15,000,000 on the Closing Date. The aggregate outstanding Term Loan Advances may be up to the Maximum Term Loan Amount. 

(b) Advance Request. To obtain a Term Loan Advance, Borrower shall complete, sign and deliver an Advance Request (at least one
(1) Business Day before the Advance Date) to Agent. Lender shall fund the Term Loan Advance in the manner requested by the Advance Request provided that each of the conditions precedent to such Term Loan Advance is satisfied as of the requested
Advance Date. 
 (c) Cash Interest. The principal balance of each Term Loan Advance shall bear interest thereon from such
Advance Date until the date the Secured Obligations are paid in full (other than unasserted contingent indemnification obligations) at the Cash Interest Rate based on a year consisting of 360 days, with interest computed daily based on the actual
number of days elapsed. The Cash Interest Rate will float and change on the day the Prime Rate changes from time to time. 

(d) Deferred PIK Interest. In addition to the interest accrued pursuant to Section 2.1(c), the principal balance of each
Term Loan Advance shall bear interest thereon from such Advance Date until the date the Secured Obligations are paid in full (other than unasserted contingent indemnification obligations) at the PIK Rate based on a year consisting of 360 days, with
interest computed daily based on the actual number of days elapsed. Interest at the PIK Rate shall be due on any monthly interest payment date and shall be paid by Borrower by adding such PIK Rate interest to the principal balance of the Term Loan
Advances outstanding on such date after giving effect to any amortization payments made pursuant to this Agreement. All interest accrued at the PIK Rate pursuant to this Section 2.1(d) shall be repaid in full by Borrower on the Term Loan
Maturity Date or when otherwise declared due and payable by Lender upon the occurrence and during the continuance of an Event of Default. 

(e) Payment. Borrower will pay interest on each Term Loan Advance on the first Business Day of each month, beginning the month
after the Advance Date. Borrower shall repay the aggregate Term Loan principal balance that is outstanding on the day immediately preceding the Amortization Date, in equal monthly installments of principal and interest (mortgage style) beginning on
the Amortization Date and continuing on the first Business Day of each month thereafter until the Secured Obligations are repaid. The entire Term Loan principal balance and all accrued but unpaid interest hereunder, shall be due and payable on Term
Loan Maturity Date. Borrower shall make all payments under this Agreement without setoff, recoupment or deduction and regardless of any counterclaim or defense. Lender will initiate debit entries to the Borrower’s account as authorized on the
ACH Authorization on each payment date of all periodic obligations (including but not limited to principal, interest and fees set forth in Section 11.11) payable to Lender under each Term Advance. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 2.2 Maximum Interest. Notwithstanding any provision in this Agreement or any other Loan Document,
it is the parties’ intent not to contract for, charge or receive interest at a rate that is greater than the maximum rate permissible by law that a court of competent jurisdiction shall deem applicable hereto (which under the laws of the State
of California shall be deemed to be the laws relating to permissible rates of interest on commercial loans) (the “Maximum Rate”). If a court of competent jurisdiction shall finally determine that Borrower has actually paid to Lender an
amount of interest in excess of the amount that would have been payable if all of the Secured Obligations had at all times borne interest at the Maximum Rate, then such excess interest actually paid by Borrower shall be applied as follows: first, to
the payment of the Secured Obligations consisting of the outstanding principal; second, after all principal is repaid, to the payment of Lender’s accrued interest, costs, expenses, professional fees and any other Secured Obligations; and third,
after all Secured Obligations are repaid, the excess (if any) shall be refunded to Borrower. 
 2.3 Default Interest. In the event any
payment is not paid on the scheduled payment date (after giving effect to any grace period provided therefor pursuant to Section 9.1), an amount equal to five percent (5%) of the past due amount shall be payable on demand. In addition,
upon the occurrence and during the continuation of an Event of Default hereunder, all Secured Obligations, including principal, interest, compounded interest, and professional fees, shall bear interest at a rate per annum equal to the rate set forth
in Section 2.1(c) and Section 2.1(d), plus five percent (5%) per annum. 
 2.4 Prepayment. At its option upon at least seven
(7) Business Days prior notice to Agent, Borrower may prepay, in whole or in part, the outstanding Advances. Any such prepayment shall include the principal amount being repaid, all accrued and unpaid interest thereon, together with a
prepayment charge equal to (a) 5% of the Advance amount being prepaid during the first twelve (12) months following the Closing Date, or (b) 1% of the Advance amount being prepaid after the first twelve (12) months following the
Closing Date (a “Prepayment Charge”). Borrower agrees that the Prepayment Charge is a reasonable calculation of Lender’s lost profits in view of the difficulties and impracticality of determining actual damages resulting from an early
repayment of the Advances. Upon the occurrence of a Change in Control, Borrower shall prepay the outstanding amount of all principal and accrued interest through the prepayment date and the Prepayment Charge. 

2.5 Notes. If so requested by Lender by written notice to Borrower, then Borrower shall execute and deliver to Lender (and/or, if applicable
and if so specified in such notice, to any Person who is an assignee of Lender pursuant to Section 11.13) (promptly after the Borrower’s receipt of such notice) a Note or Notes to evidence Lender’s Loans. 

2.6 Pro Rata Treatment. Each payment (including prepayment) on account of any fee and any reduction of the Term Loans shall be made pro rata
according to the Term Commitments of the relevant Lender. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SECTION 3. SECURITY INTEREST 

3.1 Subject to Section 3.2, as security for the payment in full when due of all the Secured Obligations (other than unasserted contingent
indemnification obligations), Borrower grants to Agent a security interest in all of Borrower’s right, title, and interest in and to the following personal property whether now owned or hereafter acquired (collectively, the
“Collateral”): (a) Receivables; (b) Equipment; (c) Fixtures; (d) General Intangibles; (e) Inventory; (f) Investment Property (but excluding thirty-five percent (35%) of the capital stock of any foreign
Subsidiary that constitutes a Permitted Investment); (g) Deposit Accounts; (h) Cash; (i) Goods; and all other tangible and intangible personal property of Borrower whether now or hereafter owned or existing, leased, consigned by or
to, or acquired by, Borrower and wherever located, and any of Borrower’s property in the possession or under the control of Agent; and, to the extent not otherwise included, all Proceeds of each of the foregoing and all accessions to,
substitutions and replacements for, and rents, profits and products of each of the foregoing. 
 3.2 Notwithstanding anything herein to the
contrary, that the Collateral will not include (a) any application for a Trademark that would otherwise be deemed invalidated, cancelled or abandoned due to the grant of a Lien thereon unless and until such time as the grant of such Lien will
not affect the validity of such trademark, (b) any lease, license (including any License), contract, or agreement, if the grant of a security interest in such lease, license, contract, or agreement under the terms thereof or under applicable
law with respect thereto, is prohibited and such prohibition has not been or is not waived or the consent of the other party to such lease, license, contract, or agreement has not been or is not otherwise obtained or under applicable law such
prohibition cannot be waived, (c) more than 65% of the voting equity interests of any Foreign Subsidiary, (d) vehicles and other goods subject to a certificate of title, (e) the Magnet Collateral, and (f) any deposit accounts
(i) used exclusively for payroll or employee benefit payment purposes and (ii) which are zero balance accounts; provided that (x) any such limitation described in the foregoing clause (b) on the security interests granted
hereunder shall only apply to the extent that any such prohibition could not be rendered ineffective pursuant to the UCC or any other applicable law or principles of equity and (y) in the event of the termination or elimination of any such
prohibition or the requirement for any consent contained in any applicable law, lease, license, contract or other agreement, to the extent sufficient to permit any such item to become Collateral hereunder, or upon the granting of any such consent,
or waiving or terminating any requirement for such consent, a security interest in such lease, license, contract or other agreement shall be automatically and simultaneously granted hereunder and shall be included as Collateral hereunder. 

SECTION 4. CONDITIONS PRECEDENT TO LOAN 

The obligations of Lender to make the Loan hereunder are subject to the satisfaction by Borrower of the following conditions: 

4.1 Initial Advance. On or prior to the Closing Date, Borrower shall have delivered to Agent the following: 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 (a) executed originals of the Loan Documents, Account Control Agreements, a legal
opinion of Borrower’s counsel, and all other documents and instruments reasonably required by Agent to effectuate the transactions contemplated hereby or to create and perfect the Liens of Agent with respect to all Collateral, in all cases in
form and substance reasonably acceptable to Agent; 
 (b) certified copy of resolutions of Borrower’s board of directors
evidencing approval of (i) the Loan and other transactions evidenced by the Loan Documents; and (ii) the Warrant and transactions evidenced thereby; 

(c) certified copies of the Certificate of Incorporation and the Bylaws, as amended through the Closing Date, of Borrower; 

(d) a certificate of good standing for Borrower from its state of incorporation and similar certificates from all other
jurisdictions in which it does business and where the failure to be qualified would have a Material Adverse Effect; 
 (e)
payment of the Facility Charge and reimbursement of Agent’s and Lender’s reasonable and documented current expenses reimbursable pursuant to this Agreement, which amounts may be deducted from the initial Advance; and 

(f) such other documents as Agent may reasonably request. 

4.2 Advance. On the Closing Date: 

(a) Agent shall have received an Advance Request for the Term Loan as required by Section 2.1(b), duly executed by
Borrower’s Chief Executive Officer or Chief Financial Officer. 
 (b) The representations and warranties set forth in
this Agreement and in Section 5 and in the Warrant shall be true and correct in all material respects on and as of the Closing Date. 

(c) Borrower shall be in compliance with all the terms and provisions set forth herein and in each other Loan Document on its
part to be observed or performed, and at the time of and immediately after such Advance no Event of Default shall have occurred and be continuing. 

(d) Since December 31, 2012, no event that has had or could reasonably be expected to have a Material Adverse Effect has
occurred and is continuing. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SECTION 5. REPRESENTATIONS AND WARRANTIES OF BORROWER 

Borrower represents and warrants that: 

5.1 Corporate Status. Borrower is a corporation duly organized, legally existing and in good standing under the laws of the State of Delaware,
and is duly qualified as a foreign corporation in all jurisdictions in which the nature of its business or location of its properties require such qualifications except where the failure to be qualified could reasonably be expected to have a
Material Adverse Effect. Borrower’s name reflected on its public organic record, jurisdiction of formation, tax identification number, organizational identification number and other information are correctly set forth in Exhibit C, as may
be updated by Borrower in a written notice (including any Compliance Certificate) provided to Agent after the Closing Date. 
 5.2
Collateral. Borrower owns, or has valid rights as a lessee or licensee with respect to, all Collateral, free of all Liens, except for Permitted Liens. Borrower has the power and authority to grant to Agent a Lien in the Collateral as security for
the Secured Obligations. 
 5.3 Consents. Borrower’s execution, delivery and performance of this Agreement and all other Loan
Documents, (i) have been duly authorized by all necessary corporate action of Borrower, (ii) will not result in the creation or imposition of any Lien upon the Collateral, other than Permitted Liens and the Liens created by this Agreement
and the other Loan Documents, (iii) do not violate any provisions of Borrower’s certificate of incorporation, bylaws, or any material applicable law, regulation, order, injunction, judgment, decree or writ to which Borrower is subject and
(iv) except as described on Schedule 5.3, do not violate any material contract or agreement or require the consent or approval of any other Person which have not already been obtained. The individual or individuals executing the Loan
Documents are duly authorized to do so. 
 5.4 Material Adverse Effect. Since December 31, 2012, no event that has had or could
reasonably be expected to have a Material Adverse Effect has occurred and is continuing. 
 5.5 Actions Before Governmental Authorities.
Except as described on Schedule 5.5, there are no actions, suits or proceedings at law or in equity or by or before any governmental authority now pending or, to the knowledge of Borrower, threatened against or affecting Borrower or its
property that, if adversely determined, could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. 

5.6 Laws. Borrower is not in violation of any law, rule or regulation, or in default with respect to any judgment, writ, injunction or decree
of any governmental authority, where such violation or default could reasonably expected to result in a Material Adverse Effect. Borrower is not in default in any manner under any provision of any material agreement or instrument evidencing
Indebtedness, or any other material agreement to which it is a party or by which it is bound. 
 5.7 Information Correct and Current. No
information, report, Advance Request, financial statement, exhibit or schedule furnished, by or on behalf of Borrower to Agent in connection with any Loan Document or included therein or delivered pursuant thereto contained, contains any material
misstatement of fact or omitted to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, and were not misleading at the time such statement was made or deemed made.
Additionally, any and all 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
financial or business projections provided by Borrower to Agent, whether prior to or after the Closing Date, shall be (i) provided in good faith and based on the most current data and
information available to Borrower, and (ii) the most current of such projections provided to Borrower’s Board of Directors (it being understood that such projections are subject to significant uncertainties and contingencies, many of which
are beyond the control of Borrower, and no assurances can be given that such projections will be realized, and although reflecting Borrower’s good faith estimate, projections or forecasts based on methods and assumptions which the Borrower
believed to be reasonable at the time such projections were prepared, are not to be viewed as facts, and that actual results during the period or periods covered by the projections may differ materially from projected or estimated results). 

5.8 Tax Matters. Except as described on Schedule 5.8, (a) Borrower has filed all material federal, state and local tax returns that
it is required to file, (b) Borrower has duly paid or reserved in accordance with GAAP for all material taxes or installments thereof (including any interest or penalties) as and when due, which have or may become due pursuant to such returns,
and (c) Borrower has paid or reserved in accordance with GAAP for any material tax assessment received by Borrower for the three (3) years preceding the Closing Date, if any (including any taxes being contested in good faith and by
appropriate proceedings). 
 5.9 Intellectual Property Claims. Except as could not reasonably be expected to have a Material Adverse Effect,
Borrower is the sole owner of, or otherwise has the right to use, the Intellectual Property. Except as described on Schedule 5.9, (i) each of the material Copyrights, Trademarks and Patents is valid and enforceable, (ii) no material
part of the Intellectual Property has been judged invalid or unenforceable, in whole or in part, and (iii) no claim has been made to Borrower that any material part of the Intellectual Property violates the rights of any third party.
Exhibit D is a true, correct and complete list of each of Borrower’s Patents, registered Trademarks, registered Copyrights, and material agreements under which Borrower licenses Intellectual Property from third parties (other than
shrink-wrap software licenses), together with application or registration numbers, as applicable, owned by Borrower or any Subsidiary, in each case as of the Closing Date. Borrower is not in material breach of, nor has Borrower failed to perform any
material obligations under, any of the foregoing contracts, licenses or agreements and, to Borrower’s knowledge, no third party to any such contract, license or agreement is in material breach thereof or has failed to perform any material
obligations thereunder. 
 5.10 Intellectual Property. Except as described on Schedule 5.10, Borrower has all material rights
with respect to Intellectual Property necessary in the operation or conduct of Borrower’s business as currently conducted by Borrower. Without limiting the generality of the foregoing, and in the case of any material Licenses necessary in the
operation or conduct of Borrower’s business as currently conducted by Borrower, except for restrictions that are unenforceable under Division 9 of the UCC, Borrower has the right, to the extent required to operate Borrower’s business,
to freely transfer, license or assign Intellectual Property without condition, restriction or payment of any kind (other than license payments in the ordinary course of business) to any third party, and Borrower owns or has the right to use,
pursuant to valid licenses, all software development tools, library functions, compilers and all other third-party software and other items that are material to the Borrower Products and used in the design, development, promotion, sale, license,
manufacture, import, export, use or distribution of Borrower Products. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 5.11 Borrower Products. Except as described on Schedule 5.11, no material
Intellectual Property owned by Borrower or Borrower Product has been or is subject to any actual or, to the knowledge of Borrower, threatened litigation, proceeding (including any proceeding in the United States Patent and Trademark Office or any
corresponding foreign office or agency) or outstanding decree, order, judgment, settlement agreement or stipulation that restricts in any manner Borrower’s use, transfer or licensing thereof or that may affect the validity, use or
enforceability thereof. There is no decree, order, judgment, agreement, stipulation, arbitral award or other provision entered into in connection with any litigation or proceeding that obligates Borrower to grant licenses or ownership interest in
any future Intellectual Property related to the operation or conduct of the business of Borrower or Borrower Products that could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Borrower has not
received any written notice or claim, or, to the knowledge of Borrower, oral notice or claim, challenging or questioning Borrower’s ownership in any Intellectual Property (or written notice of any claim challenging or questioning the ownership
in any licensed Intellectual Property of the owner thereof) or suggesting that any third party has any claim of legal or beneficial ownership with respect thereto nor, to Borrower’s knowledge, is there a reasonable basis for any such claim that
could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. To the Borrower’s knowledge, neither Borrower’s use of its Intellectual Property nor the production and sale of Borrower Products
infringes upon the rights of others in the Intellectual Property. 
 5.12 Financial Accounts. Exhibit E, as may be updated by the
Borrower in a written notice provided to Agent after the Closing Date, is a true, correct and complete list of (a) all banks and other financial institutions at which Borrower or any Subsidiary maintains Deposit Accounts and (b) all
institutions at which Borrower or any Subsidiary maintains an account holding Investment Property, and such exhibit correctly identifies the name, address and telephone number of each bank or other institution, the name in which the account is held,
a description of the purpose of the account, and the complete account number therefor. 
 5.13 Employee Loans. Except as permitted
hereunder, Borrower has no outstanding loans to any employee, officer or director of the Borrower nor has Borrower guaranteed the payment of any loan made to an employee, officer or director of the Borrower by a third party. 

5.14 Capitalization and Subsidiaries. Borrower’s capitalization as of the Closing Date is set forth on Schedule 5.14 annexed hereto.
Borrower does not own any stock, partnership interest or other securities of any Person, except for Permitted Investments. Attached as Schedule 5.14, as may be updated by Borrower in a written notice provided after the Closing Date, is a true,
correct and complete list of each Subsidiary. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SECTION 6. INSURANCE; INDEMNIFICATION 

6.1 Coverage. Borrower shall cause to be carried and maintained commercial general liability insurance, on an occurrence form, against risks
customarily insured against in Borrower’s line of business. Such risks shall include the risks of bodily injury, including death, property damage, personal injury, advertising injury, and contractual liability. Borrower must maintain a minimum
of $2,000,000 of commercial general liability insurance for each occurrence. Borrower has and agrees to maintain of directors’ and officers’ insurance of a minimum of $2,000,000 in the aggregate. So long as there are any Secured
Obligations outstanding, within 60 days after the Closing Date, Borrower shall maintain a key man life insurance policy for the Chief Executive Officer/President in an amount of $5,000,000 in form and substance reasonably satisfactory to Agent,
naming Agent as designated payee. So long as there are any Secured Obligations outstanding, Borrower shall also cause to be carried and maintained insurance upon the Collateral, insuring against all risks of physical loss or damage howsoever caused,
in an amount not less than the full replacement cost of the Collateral, provided that such insurance may be subject to standard exceptions and deductibles. 

6.2 Certificates. Borrower shall deliver to Agent certificates of insurance that evidence Borrower’s compliance with its insurance
obligations in Section 6.1 and the obligations contained in this Section 6.2. Borrower’s insurance certificate shall state Agent is an additional insured for commercial general liability, a designated payee for the key man life
insurance policy, a loss payee for all risk property damage insurance, subject to the insurer’s approval, and a loss payee for property insurance and additional insured for liability insurance for any future insurance that Borrower may acquire
from such insurer. Attached to the certificates of insurance will be additional insured endorsements for liability and lender’s loss payable endorsements for all risk property damage insurance. All certificates of insurance will provide for a
minimum of thirty (30) days advance written notice to Agent of cancellation or any other change adverse to Agent’s interests. Agent agrees that the certificates delivered to Agent as of the Closing Date are acceptable for the requirements
hereunder. 
 6.3 Indemnity. Borrower agrees to indemnify and hold Agent, Lender and their officers, directors, employees, agents, in-house attorneys, representatives and shareholders (each, an “Indemnified Person”) harmless from and against any and all claims, costs, expenses, damages and liabilities (including such claims, costs,
expenses, damages and liabilities based on liability in tort, including strict liability in tort), including reasonable attorneys’ fees and disbursements and other costs of investigation or defense (including those incurred upon any appeal)
(collectively, “Liabilities”), that may be instituted or asserted against or incurred by such Indemnified Person as the result of credit having been extended, suspended or terminated under this Agreement and the other Loan Documents or the
administration of such credit, or in connection with or arising out of the transactions contemplated hereunder and thereunder, or any actions or failures to act in connection therewith, or arising out of the disposition or utilization of the
Collateral, excluding in all cases Liabilities to the extent resulting solely from any Indemnified Person’s gross negligence or willful misconduct. Borrower agrees to pay, and to save Agent and Lender harmless from, any and all liabilities with
respect to, or resulting from any delay in paying, any and all excise, sales or other similar taxes (excluding taxes imposed on or measured by the net income of Agent or Lender) that may be payable or determined to be payable with respect to any of
the Collateral or this Agreement. In no event shall any Indemnified Person be liable on any theory of liability for any special, indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings). 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SECTION 7. COVENANTS OF BORROWER 

Borrower agrees as follows: 
 7.1
Financial Reports. Borrower shall furnish to Agent the financial statements and reports listed hereinafter (the “Financial Statements”): 

(a) as soon as practicable (and in any event within 30 days) after the end of each month, unaudited interim and
year-to-date financial statements as of the end of such month (prepared on a consolidated and consolidating basis, if applicable), including balance sheet and related statements of income and cash flows accompanied by a report detailing any material
contingencies (including the commencement of any material litigation by or against Borrower) or any other occurrence that has had a Material Adverse Effect, all certified by Borrower’s Chief Executive Officer or Chief Financial Officer to the
effect that they have been prepared in accordance with GAAP, except (i) for the absence of footnotes, (ii) that they are subject to normal year end adjustments, and (iii) they do not contain certain non-cash items that are customarily
included in quarterly and annual financial statements; 
 (b) as soon as practicable (and in any event within 30 days)
after the end of each calendar quarter, unaudited interim and year-to-date financial statements as of the end of such calendar quarter (prepared on a consolidated and consolidating basis, if applicable), including balance sheet and related
statements of income and cash flows accompanied by a report detailing any material contingencies (including the commencement of any material litigation by or against Borrower) or any other occurrence that has had a Material Adverse Effect, certified
by Borrower’s Chief Executive Officer or Chief Financial Officer to the effect that they have been prepared in accordance with GAAP, except (i) for the absence of footnotes, and (ii) that they are subject to normal year-end
adjustments; as well as the most recent capitalization table for Borrower, including the weighted average exercise price of employee stock options; 

(c) as soon as practicable (and in any event within one hundred fifty (150) days) after the end of each fiscal year,
unqualified audited financial statements as of the end of such year (prepared on a consolidated and consolidating basis, if applicable), including balance sheet and related statements of income and cash flows, and setting forth in comparative form
the corresponding figures for the preceding fiscal year, certified by a firm of independent certified public accountants selected by Borrower and reasonably acceptable to Agent, accompanied by any management report from such accountants (to the
extent received by Borrower); 
 (d) in connection with the deliverables required by Sections 7.1(a), 7.1(b) and 7.1(c),
a Compliance Certificate in the form of Exhibit F; 
 (e) as soon as practicable (and in any event within 30 days)
after the end of each month, a report showing agings of accounts receivable and accounts payable; 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 (f) as soon as practicable (and in any event within 30 days) after the end
of each month a report showing details (buyer, price, payment method, expected delivery date) of all orders for Borrower’s systems placed during the month; 

(g) promptly after the sending or filing thereof, as the case may be, copies of any proxy statements, financial statements or
reports that Borrower has made available to holders of its Preferred Stock and copies of any regular, periodic and special reports or registration statements that Borrower files with the Securities and Exchange Commission or any governmental
authority that may be substituted therefor, or any national securities exchange; 
 (h) at the same time and in the same
manner as it gives to its directors, copies of all materials that Borrower provides to its directors in connection with meetings of the board of directors; provided that in all cases Borrower may exclude confidential compensation information and any
other information relating to this Agreement, any other Loan Document, or Borrower’s relationship with Agent or Lender, or any information Borrower reasonably believes may create a conflict of interest for Agent or Lender or affect the
attorney/client or a similar privilege of any of Borrower and their legal advisors; and 
 (i) financial and business
projections promptly following their approval by Borrower’s Board of Directors, and in any event, within 45 days following the end of Borrower’s fiscal year, as well as budgets, operating plans and other financial information
reasonably requested by Agent. 
 Borrower shall not make any change in its (a) accounting policies or reporting practices, except as required by GAAP
or (b) fiscal years or fiscal quarters. The fiscal year of Borrower shall end on December 31. 
 The executed Compliance Certificate may be sent
via facsimile to Agent at (650) 473-9194 or via e-mail to cnorman@herculestech.com. All Financial Statements required to be delivered pursuant to clauses (a),
(b) and (c) shall be sent via e-mail to financialstatements@herculestech.com with a copy to cnorman@herculestech.com provided, that if e-mail is not available
or sending such Financial Statements via e-mail is not possible, they shall be sent via facsimile to Agent at: (866) 468-8916, attention Chief Credit Officer. 

7.2 Management Rights. Borrower shall permit any representative that Agent or Lender authorizes, including its attorneys and accountants, to
inspect the Collateral and examine and make copies and abstracts of the books of account and records of Borrower at reasonable times and upon reasonable prior written notice during normal business hours. In addition, any such representative shall
have the right to meet with management and officers of Borrower to discuss such books of account and records. In addition, Agent or Lender shall be entitled at reasonable times and intervals and upon reasonable prior written notice to consult with
and advise the management and officers of Borrower concerning significant business issues affecting Borrower. Such consultations shall not unreasonably interfere with Borrower’s business operations. The parties intend that the rights granted
Agent and Lender shall constitute 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
“management rights” within the meaning of 29 C.F.R Section 2510.3-101(d)(3)(ii), but that any advice, recommendations or participation by Agent or Lender with respect to any
business issues shall not be deemed to give Agent or Lender, nor be deemed an exercise by Agent or Lender of, control over Borrower’s management or policies. 

7.3 Further Assurances. Borrower shall from time to time execute, deliver and file, alone or with Agent, any financing statements, security
agreements, collateral assignments, notices, control agreements, or other documents to perfect or give the highest priority to Agent’s Lien on the Collateral. Borrower shall from time to time procure any instruments or documents as may be
reasonably requested by Agent, and take all further action that may be necessary or desirable, or that Agent may reasonably request, to perfect and protect the Liens granted hereby and thereby. In addition, and for such purposes only, Borrower
hereby authorizes Agent to file such financing statements and any amendment thereto indicating Agent’s interest in the Collateral. Borrower shall, to the extent commercially reasonable, protect and defend Borrower’s title to the Collateral
and Agent’s Lien thereon against all Persons claiming any interest adverse to Borrower or Agent other than Permitted Liens. 
 7.4
Indebtedness. Borrower shall not (a) create, incur, assume, guarantee or be or remain liable with respect to any Indebtedness, or permit any Subsidiary so to do, other than Permitted Indebtedness, or (b) prepay any Indebtedness, except
(i) in accordance with the terms of any Permitted Indebtedness (other than Subordinated Indebtedness), (ii) as permitted pursuant to any subordination or other agreement with respect to such Indebtedness with Agent or (iii) in
connection with the conversion of Indebtedness into equity interests and the payment of cash in lieu of fractional shares in connection with such conversion. 

7.5 Collateral. Borrower shall at all times keep the Collateral and all other property and assets used in Borrower’s business or in which
Borrower now or hereafter holds any interest free and clear from any legal process or Liens whatsoever (except for Permitted Liens), and, following Borrower’s knowledge thereof, shall give Agent prompt written notice of any legal process
affecting the Collateral, such other property and assets, or any Liens thereon, provided however, that the Collateral and such other property and assets may be subject to Permitted Liens. Borrower shall cause its Subsidiaries to protect and defend
such Subsidiary’s title to its assets from and against all Persons claiming any interest adverse to such Subsidiary, and Borrower shall cause its Subsidiaries at all times to keep such Subsidiary’s property and assets free and clear from
any legal process or Liens whatsoever (except for Permitted Liens), and, following Borrower’s or such Subsidiary’s knowledge thereof, shall give Agent prompt written notice of any legal process affecting such Subsidiary’s assets. 

7.6 Investments. Borrower shall not directly or indirectly acquire or own, or make any Investment in or to any Person, or permit any of its
Subsidiaries so to do, other than Permitted Investments. 
 7.7 Distributions. Borrower shall not, and shall not allow any Subsidiary to,
(a) repurchase or redeem any class of stock or other equity interest other than pursuant to employee, director or consultant repurchase plans or other similar agreements, provided, however, in each case the repurchase or redemption price does
not exceed the original 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
consideration paid for such stock or equity interest, (b) declare or pay any cash dividend or make a cash distribution on any class of stock or other equity interest, except that a
Subsidiary may pay dividends or make distributions to Borrower, (c) lend money to any employees, officers or directors or guarantee the payment of any such loans granted by a third party in excess of $250,000 in any fiscal year, (d) waive,
release or forgive any Indebtedness owed by any employees, officers or directors in excess of $250,000 in any fiscal year, or (e) repurchase or redeem for cash the Series A equity interests of Borrower held by Sasa Mutic on or prior to the date
of the first anniversary of the Closing Date; provided that such repurchase or redemption permitted by this clause (e) shall not exceed $60,000. 

7.8 Transfers. Except for Permitted Transfers, Borrower shall not voluntarily or involuntarily transfer, sell, lease, license, lend or in any
other manner convey any equitable, beneficial or legal interest in any material portion of its assets. 
 7.9 Mergers or Acquisitions.
Borrower shall not merge or consolidate, or permit any of its Subsidiaries to merge or consolidate, with or into any other business organization (other than mergers or consolidations of (a) a Subsidiary which is not a Borrower into another
Subsidiary or into Borrower or (b) a Borrower into another Borrower), or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the equity interests or property of another Person. 

7.10 Taxes. Borrower and its Subsidiaries shall pay when due all material taxes, fees or other charges of any nature whatsoever (together with
any related interest or penalties) now or hereafter imposed or assessed against Borrower or the Collateral or upon Borrower’s ownership, possession, use, operation or disposition thereof or upon Borrower’s rents, receipts or earnings
arising therefrom. Borrower shall file on or before the due date therefor all material personal property tax returns in respect of the Collateral. Notwithstanding the foregoing, Borrower shall not be in default of its obligations under this
Section 7.10 if it is contesting, in good faith and by appropriate proceedings, such taxes, fees or other charges of any nature whatsoever (together with any related interest or penalties) for which Borrower maintains adequate reserves therefor
in accordance with GAAP. 
 7.11 Corporate Changes. Neither Borrower nor any Subsidiary shall change its corporate name, legal form or
jurisdiction of formation without ten (10) Business Days’ prior written notice to Agent. Neither Borrower nor any Subsidiary shall relocate its chief executive office or its principal place of business unless: (i) it has provided
prior written notice to Agent; and (ii) such relocation shall be within the continental United States. Neither Borrower nor any Subsidiary shall relocate any item of Collateral (other than (x) sales of Inventory in the ordinary course of
business, (y) relocations of Equipment having an aggregate value of up to $150,000 in any fiscal year, and (z) relocations of Collateral from a location described on Exhibit C to another location described on Exhibit C) unless
(i) it has provided prompt written notice to Agent, (ii) such relocation is within the continental United States and, (iii) if such relocation is to a third party bailee, it has used commercially reasonable efforts to deliver a bailee
agreement in form and substance reasonably acceptable to Agent. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 7.12 Deposit Accounts. Other than Deposit Accounts (x) used exclusively for payroll or
employee benefit payment purposes, (y) which are zero balance accounts and (z) those accounts at PNC Bank, National Association for which Borrower has deposited cash collateral in support of its obligations under letters of credit in an
aggregate amount not to exceed $460,000 and credit cards in an aggregate amount not to exceed $60,000, neither Borrower nor any Subsidiary shall maintain any Deposit Accounts, or accounts holding Investment Property, except with respect to which
Agent has an Account Control Agreement. 
 7.13 Borrower shall notify Agent of each Subsidiary formed subsequent to the Closing Date and,
within 30 days of formation, shall cause any such Subsidiary to execute and deliver to Agent a Joinder Agreement. 
 7.14
[Intentionally Deleted]. 
 7.15 Notification of Event of Default. Borrower shall notify Agent immediately of the occurrence of any Event of
Default, such notice to be sent via facsimile to Agent. 
 7.16 Agent and Lender have received a license from the U.S. Small Business
Administration (“SBA”) to extend loans as a small business investment company (“SBIC”) pursuant to the Small Business Investment Act of 1958, as amended, and the associated regulations (collectively, the “SBIC Act”).
Portions of the loan to Borrower will be made under the SBA license and the SBIC Act. Addendum 1 to this Agreement outlines various responsibilities of Agent, Lender and Borrower associated with an SBA loan, and such Addendum 1 is hereby
incorporated in this Agreement. 
 7.17 Borrower shall deliver to Agent within 30 days after the Closing Date landlord consent in a
form reasonably acceptable to Agent for the office located in Oakwood Village, Ohio. 
 SECTION 8. RIGHT TO INVEST 

8.1 Lender or its assignee or nominee shall have the right, in its discretion, to participate in any Subsequent Financing in an amount of up to
$1,000,000 on the same terms, conditions and pricing afforded to others participating in any such Subsequent Financing. 

SECTION 9. EVENTS OF DEFAULT 

The occurrence of any one or more of the following events shall be an Event of Default: 

9.1 Payments. Borrower fails to pay any amount due under this Agreement or any of the other Loan Documents on the due date (unless such non
payment is the result of Lender’s failure to debit the Borrower’s accounts, in which case Borrower shall pay within 3 Business Days after Lender’s request of such payment); or 

9.2 Covenants. Borrower breaches or defaults in the performance of any covenant or Secured Obligation under this Agreement, or any of the
other Loan Documents or any other agreement among Borrower, Agent and Lender, and (a) with respect to a default under any 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
covenant under this Agreement (other than under Sections 6, 7.4, 7.5, 7.6, 7.7, 7.8, 7.9, 7.15, 7.16 and 7.17), any other Loan Document or any other agreement among Borrower, Agent and
Lender, such default continues for more than fifteen (15) days after the earlier of the date on which (i) Agent or Lender has given notice of such default to Borrower and (ii) Borrower has actual knowledge of such default or
(b) with respect to a default under any of Sections 6, 7.4, 7.5, 7.6, 7.7, 7.8, 7.9,7.15, 7.16 and 7.17 the occurrence of such default; or 

9.3 Material Adverse Effect. There occurs a Material Adverse Effect; or 

9.4 Representations. Any representation or warranty made by Borrower in any Loan Document shall have been false or misleading in any material
respect; or 
 9.5 Insolvency. Borrower (A) (i) shall make an assignment for the benefit of creditors; or (ii) shall be
unable to pay its debts as they become due, or be unable to pay or perform under the Loan Documents, or shall become insolvent; or (iii) shall file a voluntary petition in bankruptcy; or (iv) shall file any petition, answer, or document
seeking for itself any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief under any present or future statute, law or regulation pertinent to such circumstances; or (v) shall seek or consent to or
acquiesce in the appointment of any trustee, receiver, or liquidator of Borrower or of all or any substantial part (i.e., 33-1/3% or more) of the assets or property of Borrower; or (vi) shall cease
operations of its business as its business has normally been conducted, or terminate substantially all of its employees; or (vii) Borrower or its directors or majority shareholders shall take any action initiating any of the foregoing actions
described in clauses (i) through (vi); or (B) either (i) sixty (60) days shall have expired after the commencement of an involuntary action against Borrower seeking reorganization, arrangement, composition, readjustment,
liquidation, dissolution or similar relief under any present or future statute, law or regulation, without such action being dismissed or all orders or proceedings thereunder affecting the operations or the business of Borrower being stayed; or
(ii) a stay of any such order or proceedings shall thereafter be set aside and the action setting it aside shall not be timely appealed; or (iii) Borrower shall file any answer admitting or not contesting the material allegations of a
petition filed against Borrower in any such proceedings; or (iv) the court in which such proceedings are pending shall enter a decree or order granting the relief sought in any such proceedings; or (v) sixty (60) days shall have
expired after the appointment, without the consent or acquiescence of Borrower, of any trustee, receiver or liquidator of Borrower or of all or any substantial part of the properties of Borrower without such appointment being vacated; or 

9.6 Attachments; Judgments. Any one or more judgments or decrees involving an aggregate amount (to the extent not paid or fully bonded or
covered by insurance as to which the surety or insurer, as the case may be, has the financial ability to perform and has acknowledged liability in writing) in excess of $250,000 shall be entered or filed against Borrower or any of its properties and
the same shall not be paid, dismissed, bonded, vacated, stayed or discharged within a period of 30 days; or 
 9.7 Other Obligations.
The occurrence of any default under any agreement or obligation of Borrower involving any Indebtedness (other than trade credit incurred in the ordinary course of business so long as disputed in good faith with adequate reserves) in excess of
$250,000. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SECTION 10. REMEDIES 

10.1 General. Upon and during the continuance of any one or more Events of Default, (i) Agent may, at its option, accelerate and demand
payment of all or any part of the Secured Obligations together with a Prepayment Charge and declare them to be immediately due and payable (provided, that upon the occurrence of an Event of Default of the type described in Section 9.5, all of
the Secured Obligations shall automatically be accelerated and made due and payable, in each case without any further notice or act), (ii) Agent may, at its option, sign and file in Borrower’s name any and all collateral assignments,
notices, control agreements, security agreements and other documents it deems necessary or appropriate to perfect or protect the repayment of the Secured Obligations, and in furtherance thereof, Borrower hereby grants Agent an irrevocable power of
attorney coupled with an interest, and (iii) Agent may notify any of Borrower’s account debtors to make payment directly to Agent, compromise the amount of any such account on Borrower’s behalf and endorse Agent’s name without
recourse on any such payment for deposit directly to Agent’s account. Agent may exercise all rights and remedies with respect to the Collateral under the Loan Documents or otherwise available to it under the UCC and other applicable law,
including the right to release, hold, sell, lease, liquidate, collect, realize upon, or otherwise dispose of all or any part of the Collateral and the right to occupy, utilize, process and commingle the Collateral. All Agent’s rights and
remedies shall be cumulative and not exclusive. 
 10.2 Collection; Foreclosure. Upon the occurrence and during the continuance of any Event
of Default, Agent may, at any time or from time to time, apply, collect, liquidate, sell in one or more sales, lease or otherwise dispose of, any or all of the Collateral, in its then condition or following any commercially reasonable preparation or
processing, in such order as Agent may elect. Any such sale may be made either at public or private sale at its place of business or elsewhere. Borrower agrees that any such public or private sale may occur upon ten (10) calendar days’
prior written notice to Borrower. Agent may require Borrower to assemble the Collateral and make it available to Agent at a place designated by Agent that is reasonably convenient to Agent and Borrower. The proceeds of any sale, disposition or other
realization upon all or any part of the Collateral shall be applied by Agent in the following order of priorities: 
 First, to Agent and
Lender in an amount sufficient to pay in full Agent’s and Lender’s costs and professionals’ and advisors’ fees and expenses as described in Section 11.11; 

Second, to Lender in an amount equal to the then unpaid amount of the Secured Obligations (including principal, interest, and the Default Rate
interest), in such order and priority as Agent may choose in its sole discretion; and 
 Finally, after the full, final, and indefeasible
payment in Cash of all of the Secured Obligations, to any creditor holding a junior Lien on the Collateral, or to Borrower or its representatives or as a court of competent jurisdiction may direct. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Agent shall be deemed to have acted reasonably in the custody, preservation and disposition of any of the
Collateral if it complies with the obligations of a secured party under the UCC. 
 10.3 No Waiver. Agent shall be under no obligation to
marshal any of the Collateral for the benefit of Borrower or any other Person, and Borrower expressly waives all rights, if any, to require Agent to marshal any Collateral. 

10.4 Cumulative Remedies. The rights, powers and remedies of Agent hereunder shall be in addition to all rights, powers and remedies given by
statute or rule of law and are cumulative. The exercise of any one or more of the rights, powers and remedies provided herein shall not be construed as a waiver of or election of remedies with respect to any other rights, powers and remedies of
Agent. 
 SECTION 11. MISCELLANEOUS 

11.1 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement shall be prohibited by or invalid under such law, such provision shall be ineffective only to the extent and duration of such prohibition or invalidity, without invalidating the remainder of
such provision or the remaining provisions of this Agreement. 
 11.2 Notice. Except as otherwise provided herein, any notice, demand,
request, consent, approval, declaration, service of process or other communication (including the delivery of Financial Statements) that is required, contemplated, or permitted under the Loan Documents or with respect to the subject matter hereof
shall be in writing, and shall be deemed to have been validly served, given, delivered, and received upon the earlier of: (i) the day of transmission by facsimile or hand delivery or delivery by an overnight express service or overnight mail
delivery service; or (ii) the third calendar day after deposit in the United States mails, with proper first class postage prepaid, in each case addressed to the party to be notified as follows: 

 

	 	(a)	If to Agent: 

 HERCULES TECHNOLOGY GROWTH CAPITAL, INC. 

Legal Department 
 Attention:
Chief Legal Officer and Chad Norman 
 400 Hamilton Avenue, Suite 310 

Palo Alto, CA 94301 

Facsimile: 650-473-9194 

Telephone: 650-289-3060 
  

	 	(b)	If to Lender: 

 HERCULES TECHNOLOGY III, L.P. 

Legal Department 
 Attention:
Chief Legal Officer and Chad Norman 
 400 Hamilton Avenue, Suite 310 

Palo Alto, CA 94301 

Facsimile: 650-473-9194 

Telephone: 650-289-3060 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








	 	(c)	If to Borrower: 

 ViewRay Incorporated 

2 Thermo Fisher Way 

Bedford, OH 44146 

Attention: Chief Financial Officer 

Facsimile: 800.417.3459 

Telephone: 440.703.3210 
 with a
copy (which shall not constitute notice or delivery) to: 
 Bingham McCutchen LLP 

One Federal Street 

Boston, MA 02110 

Attention: Julio Vega 

Facsimile: 617.345.5016 
 or to such other
address as each party may designate for itself by like notice. 
 11.3 Entire Agreement; Amendments. 

(a) This Agreement and the other Loan Documents constitute the entire agreement and understanding of the parties hereto in
respect of the subject matter hereof and thereof, and supersede and replace in their entirety any prior proposals, term sheets, non-disclosure or confidentiality agreements, letters, negotiations or other documents or agreements, whether written or
oral, with respect to the subject matter hereof or thereof (including Agent’s revised proposal letter dated October 3, 2013). 

(b) Neither this Agreement, any other Loan Document, nor any terms hereof or thereof may be amended, supplemented or modified
except in accordance with the provisions of this Section 11.3(b). The Required Lenders, Borrower, Agent any other Person party to the relevant Loan Document may, or, with the written consent of the Required Lenders, the Agent and the Borrower
party to the relevant Loan Document may, from time to time, (i) enter into written amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this Agreement or the other Loan
Documents or changing in any manner the rights of the Lenders or of the Borrower hereunder or thereunder or (ii) waive, on such terms and conditions as the Required Lenders or the Agent, as the case may be, may specify in such instrument, any
of the requirements of this Agreement or the other Loan Documents or any default or Event of Default and its consequences; provided, however, that no such waiver and no such amendment, supplement or modification shall (A) forgive the principal
amount or extend the final scheduled date of maturity of any Loan, extend the scheduled date of any amortization payment in respect of any Term Loan, reduce the 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
stated rate of any interest or fee payable hereunder) or extend the scheduled date of any payment thereof, in each case without the written consent of each Lender directly affected thereby;
(B) eliminate or reduce the voting rights of any Lender under this Section 11.3(b) without the written consent of such Lender; (C) reduce any percentage specified in the definition of Required Lenders, consent to the assignment or
transfer by the Borrower of any of its rights and obligations under this Agreement and the other Loan Documents, release all or substantially all of the Collateral or release a Borrower from its obligations under the Loan Documents, in each case
without the written consent of all Lenders; or (D) amend, modify or waive any provision of Section 11.17 without the written consent of the Agent. Any such waiver and any such amendment, supplement or modification shall apply equally to
each Lender and shall be binding upon Borrower, the Lender, the Agent and all future holders of the Loans. 
 11.4 No Strict Construction.
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto
and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement. 

11.5 No Waiver. The powers conferred upon Agent and Lender by this Agreement are solely to protect its rights hereunder and under the other
Loan Documents and its interest in the Collateral and shall not impose any duty upon Agent or Lender to exercise any such powers. No omission or delay by Agent or Lender at any time to enforce any right or remedy reserved to it, or to require
performance of any of the terms, covenants or provisions hereof by Borrower at any time designated, shall be a waiver of any such right or remedy to which Agent or Lender is entitled, nor shall it in any way affect the right of Agent or Lender to
enforce such provisions thereafter. 
 11.6 Survival. All agreements, representations and warranties contained in this Agreement and the
other Loan Documents or in any document delivered pursuant hereto or thereto shall be for the benefit of Agent and Lender and shall survive the execution and delivery of this Agreement and the expiration or other termination of this Agreement. 

11.7 Successors and Assigns. The provisions of this Agreement and the other Loan Documents shall inure to the benefit of and be binding on
Borrower and its permitted assigns (if any). Borrower shall not assign its obligations under this Agreement or any of the other Loan Documents without Agent’s express prior written consent, and any such attempted assignment shall be void and of
no effect. Subject to Section 11.13, Agent and Lender may assign, transfer, or endorse its rights hereunder and under the other Loan Documents without prior notice to Borrower, and all of such rights shall inure to the benefit of Agent’s
and Lender’s successors and assigns. 
 11.8 Governing Law. This Agreement and the other Loan Documents have been negotiated and
delivered to Agent and Lender in the State of California, and shall have been accepted by Agent and Lender in the State of California. Payment to Agent and Lender by Borrower of the Secured Obligations is due in the State of California. This
Agreement and the 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
other Loan Documents shall be governed by, and construed and enforced in accordance with, the laws of the State of California, excluding conflict of laws principles that would cause the
application of laws of any other jurisdiction. 
 11.9 Consent to Jurisdiction and Venue. All judicial proceedings (to the extent that the
reference requirement of Section 11.10 is not applicable) arising in or under or related to this Agreement or any of the other Loan Documents may be brought in any state or federal court located in the State of California. By execution and
delivery of this Agreement, each party hereto generally and unconditionally: (a) consents to nonexclusive personal jurisdiction in Santa Clara County, State of California; (b) waives any objection as to jurisdiction or venue in Santa Clara
County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and (d) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Agreement or
the other Loan Documents. Service of process on any party hereto in any action arising out of or relating to this Agreement shall be effective if given in accordance with the requirements for notice set forth in Section 11.2, and shall be
deemed effective and received as set forth in Section 11.2. Nothing herein shall affect the right to serve process in any other manner permitted by law or shall limit the right of either party to bring proceedings in the courts of any other
jurisdiction. 
 11.10 Mutual Waiver of Jury Trial / Judicial Reference. 

(a) Because disputes arising in connection with complex financial transactions are most quickly and economically resolved by an
experienced and expert Person and the parties wish applicable state and federal laws to apply (rather than arbitration rules), the parties desire that their disputes be resolved by a judge applying such applicable laws. EACH OF BORROWER, AGENT AND
LENDER SPECIFICALLY WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY, “CLAIMS”) ASSERTED BY BORROWER AGAINST AGENT, LENDER OR THEIR
RESPECTIVE ASSIGNEE OR BY AGENT, LENDER OR THEIR RESPECTIVE ASSIGNEE AGAINST BORROWER. This waiver extends to all such Claims, including Claims that involve Persons other than Agent, Borrower and Lender; Claims that arise out of or are in any way
connected to the relationship among Borrower, Agent and Lender; and any Claims for damages, breach of contract, tort, specific performance, or any equitable or legal relief of any kind, arising out of this Agreement, any other Loan Document. 

(b) If the waiver of jury trial set forth in Section 11.10(a) is ineffective or unenforceable, the parties agree that all
Claims shall be resolved by reference to a private judge sitting without a jury, pursuant to Code of Civil Procedure Section 638, before a mutually acceptable referee or, if the parties cannot agree, a referee selected by the Presiding Judge of
the Santa Clara County, California. Such proceeding shall be conducted in Santa Clara County, California, with California rules of evidence and discovery applicable to such proceeding. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 (c) In the event Claims are to be resolved by judicial reference, either party
may seek from a court identified in Section 11.9, any prejudgment order, writ or other relief and have such prejudgment order, writ or other relief enforced to the fullest extent permitted by law notwithstanding that all Claims are otherwise
subject to resolution by judicial reference. 
 11.11 Professional Fees. Borrower promises to pay Agent’s and Lender’s reasonable
and documented fees and expenses necessary to finalize the loan documentation, including but not limited to reasonable and documented attorneys fees, UCC searches, filing costs, and other miscellaneous expenses. In addition, Borrower promises to pay
any and all reasonable and documented attorneys’ and other professionals’ fees and expenses (including fees and expenses of in-house counsel) incurred by Agent and Lender after the Closing Date in
connection with or related to: (a) the Loan; (b) the administration, collection, or enforcement of the Loan; (c) the amendment or modification of the Loan Documents; (d) any waiver, consent, release, or termination under the Loan
Documents; (e) the protection, preservation, audit, field exam, sale, lease, liquidation, or disposition of Collateral or the exercise of remedies with respect to the Collateral; (f) any legal, litigation, administrative, arbitration, or
out of court proceeding in connection with or related to Borrower or the Collateral, and any appeal or review thereof; and (g) any bankruptcy, restructuring, reorganization, assignment for the benefit of creditors, workout, foreclosure, or
other action related to Borrower, the Collateral, the Loan Documents, including representing Agent or Lender in any adversary proceeding or contested matter commenced or continued by or on behalf of Borrower’s estate, and any appeal or review
thereof. 
 11.12 Confidentiality. Agent and Lender acknowledge that certain items of Collateral and information provided to Agent and
Lender by Borrower are confidential and proprietary information of Borrower, if and to the extent such information either (x) is marked as confidential by Borrower at the time of disclosure, or (y) should reasonably be understood to be
confidential (the “Confidential Information”). Accordingly, Agent and Lender agree that any Confidential Information it may obtain in the course of acquiring, administering, or perfecting Agent’s security interest in the Collateral
shall not be disclosed to any other Person or entity in any manner whatsoever, in whole or in part, without the prior written consent of Borrower, except that Agent and Lender may disclose any such information: (a) to its own directors,
officers, employees, accountants, counsel and other professional advisors and to its affiliates if Agent or Lender in their sole discretion determines that any such party should have access to such information in connection with such party’s
responsibilities in connection with the Loan or this Agreement and, provided that such recipient of such Confidential Information either (i) agrees to be bound by the confidentiality provisions of this paragraph or (ii) is otherwise
subject to confidentiality restrictions that reasonably protect against the disclosure of Confidential Information; (b) if such information is generally available to the public; (c) if required or appropriate in any report, statement or
testimony submitted to any governmental authority having or claiming to have jurisdiction over Agent or Lender; (d) if required or appropriate in response to any summons or subpoena or in connection with any litigation, to the extent permitted
or deemed advisable by Agent’s or Lender’s counsel; (e) to comply with any legal requirement or law applicable to Agent or Lender; (f) to the extent reasonably necessary in connection with the exercise of any right or remedy
under any Loan Document, including Agent’s sale, lease, or other disposition of Collateral after default; (g) to any participant or 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
assignee of Agent or Lender or any prospective participant or assignee; provided, that such participant or assignee or prospective participant or assignee agrees in writing to be bound by this
Section prior to disclosure; or (h) otherwise with the prior consent of Borrower; provided, that any disclosure made in violation of this Agreement shall not affect the obligations of Borrower or any of its affiliates or any guarantor under
this Agreement or the other Loan Documents. 
 11.13 Assignment of Rights. Borrower acknowledges and understands that Agent or Lender may
sell and assign all or part of its interest hereunder and under the Loan Documents to any Person or entity (an “Assignee”); provided, that so long as no Event of Default has occurred and is continuing, Agent or Lender can only assign any
interest hereunder or under the Loan Documents to a Person who is an Affiliate of Lender or Agent or an Eligible Assignee with thirty (30) days prior notice to Borrower. After such assignment the term “Agent” or “Lender” as
used in the Loan Documents shall mean and include such Assignee, and such Assignee shall be vested with all rights, powers and remedies of Agent and Lender hereunder with respect to the interest so assigned; but with respect to any such interest not
so transferred, Agent and Lender shall retain all rights, powers and remedies hereby given. No such assignment by Agent or Lender shall relieve Borrower of any of its obligations hereunder. Lender agrees that in the event of any transfer by it of
the Note(s)(if any), it will endorse thereon a notation as to the portion of the principal of the Note(s), which shall have been paid at the time of such transfer and as to the date to which interest shall have been last paid thereon. 

11.14 Revival of Secured Obligations. This Agreement and the Loan Documents shall remain in full force and effect and continue to be effective
if any petition is filed by or against Borrower for liquidation or reorganization, if Borrower becomes insolvent or makes an assignment for the benefit of creditors, if a receiver or trustee is appointed for all or any significant part of
Borrower’s assets, or if any payment or transfer of Collateral is recovered from Agent or Lender. The Loan Documents and the Secured Obligations and Collateral security shall continue to be effective, or shall be revived or reinstated, as the
case may be, if at any time payment and performance of the Secured Obligations or any transfer of Collateral to Agent, or any part thereof is rescinded, avoided or avoidable, reduced in amount, or must otherwise be restored or returned by, or is
recovered from, Agent, Lender or by any obligee of the Secured Obligations, whether as a “voidable preference,” “fraudulent conveyance,” or otherwise, all as though such payment, performance, or transfer of Collateral had not
been made. In the event that any payment, or any part thereof, is rescinded, reduced, avoided, avoidable, restored, returned, or recovered, the Loan Documents and the Secured Obligations shall be deemed, without any further action or documentation,
to have been revived and reinstated except to the extent of the full, final, and indefeasible payment to Agent or Lender in Cash. 
 11.15
Counterparts. This Agreement and any amendments, waivers, consents or supplements hereto may be executed in any number of counterparts, and by different parties hereto in separate counterparts, each of which when so delivered shall be deemed an
original, but all of which counterparts shall constitute but one and the same instrument. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 11.16 No Third Party Beneficiaries. No provisions of the Loan Documents are intended, nor will be
interpreted, to provide or create any third-party beneficiary rights or any other rights of any kind in any Person other than Agent, Lender and Borrower unless specifically provided otherwise herein, and, except as otherwise so provided, all
provisions of the Loan Documents will be personal and solely among Agent, the Lender and the Borrower. 
 11.17 Agency. 

(a) Lender hereby irrevocably appoints Hercules Technology Growth Capital, Inc. to act on its behalf as the Agent hereunder and
under the other Loan Documents and authorizes the Agent to take such actions on its behalf and to exercise such powers as are delegated to the Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental
thereto. 
 (b) Lender agrees to indemnify the Agent in its capacity as such (to the extent not reimbursed by Borrower and
without limiting the obligation of Borrower to do so), according to its respective Term Commitment percentages (based upon the total outstanding Term Loan Commitments) in effect on the date on which indemnification is sought under this
Section 11.7, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever that may at any time be imposed on, incurred by or asserted
against the Agent in any way relating to or arising out of, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or
omitted by the Agent under or in connection with any of the foregoing; The agreements in this Section shall survive the payment of the Loans and all other amounts payable hereunder. 

(c) Agent in Its Individual Capacity. The Person serving as the Agent hereunder shall have the same rights and powers in its
capacity as a Lender as any other Lender and may exercise the same as though it were not the Agent and the term “Lender” shall, unless otherwise expressly indicated or unless the context otherwise requires, include each such Person serving
as Agent hereunder in its individual capacity. 
 (d) Exculpatory Provisions. The Agent shall have no duties or obligations
except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Agent shall not: 
  

	 	(i)	be subject to any fiduciary or other implied duties, regardless of whether any default or any Event of Default has occurred and is continuing; 


 

	 	(ii)	have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Agent is required to
exercise as directed in writing by the Lender, provided that the Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Agent to liability or that is contrary to any Loan Document or
applicable law; and 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








	 	(iii)	except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and the Agent shall not be liable for the failure to disclose, any information relating to the Borrower or any of its
affiliates that is communicated to or obtained by any Person serving as the Agent or any of its affiliates in any capacity. 


(e) The Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the
Lender or as the Agent shall believe in good faith shall be necessary, under the circumstances or (ii) in the absence of its own gross negligence or willful misconduct. 

(f) The Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or
representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the
performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any default or Event of Default, (iv) the validity, enforceability, effectiveness or genuineness of this
Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in Section 4 or elsewhere herein, other than to confirm receipt of items expressly required to be
delivered to the Agent. 
 (g) Reliance by Agent. Agent may rely, and shall be fully protected in acting, or refraining to
act, upon, any resolution, statement, certificate, instrument, opinion, report, notice, request, consent, order, bond or other paper or document that it has no reason to believe to be other than genuine and to have been signed or presented by the
proper party or parties or, in the case of cables, telecopies and telexes, to have been sent by the proper party or parties. In the absence of its gross negligence or willful misconduct, Agent may conclusively rely, as to the truth of the statements
and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to Agent and conforming to the requirements of the Loan Agreement or any of the other Loan Documents. Agent may consult with counsel, and any opinion
or legal advice of such counsel shall be full and complete authorization and protection in respect of any action taken, not taken or suffered by Agent hereunder or under any Loan Documents in accordance therewith. Agent shall have the right at any
time to seek instructions concerning the administration of the Collateral from any court of competent jurisdiction. Agent shall not be under any obligation to exercise any of the rights or powers granted to Agent by this Agreement, the Loan
Agreement and the other Loan Documents at the request or direction of Lenders unless Agent shall have been provided by Lender with adequate security and indemnity against the costs, expenses and liabilities that may be incurred by it in compliance
with such request or direction. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 11.18 Publicity. (a) Borrower consents to the publication and use by Agent or Lender and any
of its member businesses and affiliates of (i) Borrower’s name (including a brief description of the relationship among Borrower, Agent and Lender) and logo and a hyperlink to Borrower’s web site, separately or together, in written
and oral presentations, advertising, promotional and marketing materials, client lists, public relations materials or on its web site (together, the “Lender Publicity Materials”); (ii) the names of officers of Borrower in the Lender
Publicity Materials; and (iii) Borrower’s name, trademarks or servicemarks in any news release concerning Agent or Lender. 

(b) Neither Borrower nor any of its member businesses and affiliates shall, without Agent’s and Lender’s consent,
publicize or use (i) Agent’s or Lender’s name (including a brief description of the relationship among Borrower, Agent and Lender), logo or hyperlink to Agent’s or Lender’s web site, separately or together, in written and
oral presentations, advertising, promotional and marketing materials, client lists, public relations materials or on its web site (together, the “Borrower Publicity Materials”); (ii) the names of officers of Agent or Lender in the
Borrower Publicity Materials; and (iii) Agent’s or Lender’s name, trademarks, servicemarks in any news release concerning Borrower. 

(SIGNATURES TO FOLLOW) 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 IN WITNESS WHEREOF, Borrower, Agent and Lender have duly executed and delivered this Loan and
Security Agreement as of the day and year first above written. 
  

			
	BORROWER:
	
	VIEWRAY INCORPORATED
		
	Signature:		/s/ D. David Chandler
	Print Name:		DAVID CHANDLER
	Title:		CFO


 Accepted in Palo Alto, California: 

 

			
	AGENT:
	
	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
		
	Signature:		/s/ Ben Bang
	Print Name:		Ben Bang
	Title:		SENIOR COUNSEL
	
	LENDER:
	
	 HERCULES TECHNOLOGY III, L.P.,
 a
Delaware limited partnership

		
	By:		Hercules Technology SBIC Management, LLC, its General Partner
		
	By:		Hercules Technology Growth Capital, Inc., its Manager
		
	By:		/s/ Ben Bang
	Name:		Ben Bang
	Its:		SENIOR COUNSEL



  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

[Signature Page to Loan and Security Agreement] 







 Table of Addenda, Exhibits and Schedules 

 

	Addendum 1:	SBA Provisions 

  

	Exhibit A:	Advance Request Attachment to Advance Request 

  

	Exhibit B:	Term Note 

  

	Exhibit C:	Name, Locations, and Other Information for Borrower 

  

	Exhibit D:	Borrower’s Patents, Trademarks, Copyrights and Licenses 

  

	Exhibit E:	Borrower’s Deposit Accounts and Investment Accounts 

  

	Exhibit F:	Compliance Certificate 

  

	Exhibit G:	Joinder Agreement 

  

	Exhibit H:	ACH Debit Authorization Agreement 

  

	Schedule 1	Subsidiaries 


	Schedule 1.1	Commitments 


	Schedule 1.2	Description of Magnet Collateral 


	Schedule 1A	Existing Permitted Indebtedness 


	Schedule 1B	Existing Permitted Investments 


	Schedule 1C	Existing Permitted Liens 


	Schedule 5.3	Consents, Etc. 


	Schedule 5.5	Actions Before Governmental Authorities 


	Schedule 5.8	Tax Matters 


	Schedule 5.9	Intellectual Property Claims 


	Schedule 5.10	Intellectual Property 


	Schedule 5.11	Borrower Products 


	Schedule 5.14	Capitalization 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 ADDENDUM 1 to LOAN AND SECURITY AGREEMENT 

(a) Borrower’s Business. For purposes of this Addendum 1, Borrower shall be deemed to include its
“affiliates” as defined in Title 13 Code of Federal Regulations Section 121.103. Borrower represents and warrants to Agent and Lender as of the Closing Date and covenants to Agent and Lender for a period of one year after the
Closing Date with respect to subsections 2, 3, 4, 5, 6 and 7 below, as follows: 
  

	 	1.	Size Status. Borrower does not have tangible net worth in excess of $18 million or average net income after Federal income taxes (excluding any carry-over losses) for the preceding two completed fiscal years in
excess of $6 million. 

  

	 	2.	No Relender. Borrower’s primary business activity does not involve, directly or indirectly, providing funds to others, purchasing debt obligations, factoring, or long-term leasing of equipment with no provision for
maintenance or repair. 

  

	 	3.	No Passive Business. Borrower is engaged in a regular and continuous business operation (excluding the mere receipt of payments such as dividends, rents, lease payments, or royalties). Borrower’s employees are
carrying on the majority of day to day operations. Borrower will not pass through substantially all of the proceeds of the Loan to another entity. 

  

	 	4.	No Real Estate Business. Borrower is not classified under Major Group 65 (Real Estate) or Industry No. 1531 (Operative Builders) of the SIC Manual. The proceeds of the Loan will not be used to acquire or refinance
real property unless Borrower (x) is acquiring an existing property and will use at least 51 percent of the usable square footage for its business purposes; (y) is building or renovating a building and will use at least
67 percent of the usable square footage for its business purposes; or (z) occupies the subject property and uses at least 67 percent of the usable square footage for its business purposes. 


 

	 	5.	No Project Finance. Borrower’s assets are not intended to be reduced or consumed, generally without replacement, as the life of its business progresses, and the nature of Borrower’s business does not require
that a stream of cash payments be made to the business’s financing sources, on a basis associated with the continuing sale of assets (e.g., real estate development projects and oil and gas wells). The primary purpose of the Loan is not to fund
production of a single item or defined limited number of items, generally over a defined production period, where such production will constitute the majority of the activities of Borrower (e.g., motion pictures and electric generating plants).



  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








	 	6.	No Farm Land Purchases. Borrower will not use the proceeds of the Loan to acquire farm land which is or is intended to be used for agricultural or forestry purposes, such as the production of food, fiber, or wood, or is
so taxed or zoned. 

  

	 	7.	No Foreign Investment. The proceeds of the Loan will not be used substantially for a foreign operation. At the time of the Loan, Borrower will not have more than 49 percent of its employees or tangible assets
located outside the United States. The representation in this subsection (7) is made only as of the date hereof and shall not continue for one year as contemplated in the first sentence of this Section 1. 


(b) Small Business Administration Documentation. Agent and Lender acknowledge that Borrower completed, executed and delivered to
Agent SBA Forms 480, 652 and 1031 (Parts A and B) together with a business plan showing Borrower’s financial projections (including balance sheets and income and cash flows statements) for the period described therein and a written
statement (whether included in the purchase agreement or pursuant to a separate statement) from Agent regarding its intended use of proceeds from the sale of securities to Lender (the “Use of Proceeds Statement”). Borrower represents and
warrants to Agent and Lender that the information regarding Borrower and its affiliates set forth in the SBA Form 480, Form 652 and Form 1031 and the Use of Proceeds Statement delivered as of the Closing Date is accurate and
complete. 
 (c) Inspection. The following covenants contained in this Section (c) are intended to supplement and
not to restrict the related provisions of the Loan Documents. Subject to the preceding sentence, Borrower will permit, for so long as Lender holds any debt or equity securities of Borrower, Agent, Lender or their representative, at Agent’s or
Lender’ expense, and examiners of the SBA to visit and inspect the properties and assets of Borrower, to examine its books of account and records, and to discuss Borrower’s affairs, finances and accounts with Borrower’s officers,
senior management and accountants, all at such reasonable times as may be requested by Agent or Lender or the SBA and shall be during normal business hours of Borrower. 

(d) Annual Assessment. Promptly after the end of each calendar year (but in any event prior to February 28 of each year)
and at such other times as may be reasonably requested by Agent or Lender, Borrower will deliver to Agent a written assessment of the economic impact of Lender’s investment in Borrower, specifying the full-time equivalent jobs created or
retained in connection with the investment, the impact of the investment on the businesses of Borrower in terms of expanded revenue and taxes, other economic benefits resulting from the investment (such as technology development or
commercialization, minority business development, or expansion of exports) and such other information as may be required regarding Borrower in connection with the filing of Lender’s SBA Form 468. Lender will assist Borrower with preparing
such assessment. In addition to any other rights granted hereunder, Borrower will grant Agent and Lender and the SBA access to Borrower’s books and records for the purpose of verifying the use of such proceeds (provided Agent and Lender may not
use such right to take any action otherwise prohibited by the Loan Documents and shall use such right solely for  

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
compliance with the rules and regulations of the SBIC Act). Borrower also will furnish or cause to be furnished to Agent and Lender such other information regarding the business, affairs and
condition of Borrower as Agent or Lender may from time to time reasonably request. 
 (e) Use of Proceeds. Borrower will use
the proceeds from the Loan only for purposes set forth in Section 7.16. Borrower will deliver to Agent from time to time promptly following Agent’s request, a written report, certified as correct by Borrower’s Chief Financial Officer,
verifying the purposes and amounts for which proceeds from the Loan have been disbursed. Borrower will supply to Agent such additional information and documents as Agent reasonably requests with respect to its use of proceeds and will permit Agent
and Lender and the SBA to have access to any and all Borrower records and information and personnel as Agent deems necessary to verify how such proceeds have been or are being used, and to assure that the proceeds have been used for the purposes
specified in Section 7.16. 
 (f) Activities and Proceeds. Neither Borrower nor any of its affiliates (if any)
will engage in any activities or use directly or indirectly the proceeds from the Loan for any purpose for which a small business investment company is prohibited from providing funds by the SBIC Act, including 13 C.F.R. §107.720. Without
obtaining the prior written approval of Agent, Borrower will not change within 1 year of the date hereof, Borrower’s current business activity to a business activity which a licensee under the SBIC Act is prohibited from providing funds by
the SBIC Act. 
 (g) Redemption Provisions. Notwithstanding any provision to the contrary contained in the Certificate
of Incorporation of Borrower, as amended from time to time (the “Charter”), if, pursuant to the redemption provisions contained in the Charter, Lender is entitled to a redemption of its Warrant, such redemption (in the case of Lender) will
be at a price equal to the redemption price set forth in the Charter (the “Existing Redemption Price”). If, however, Lender delivers written notice to Borrower that the then current regulations promulgated under the SBIC Act prohibit
payment of the Existing Redemption Price in the case of an SBIC (or, if applied, the Existing Redemption Price would cause the Series C Preferred Stock to lose its classification as an “equity security” and Lender has determined that such
classification is unadvisable), then Borrower and Lender shall negotiate in good faith a redemption price which shall be in compliance with the then applicable rules and regulations of the SBIC Act; provided, however, the amount calculated in
subsections (i) or (ii) above shall not exceed the Existing Redemption Price. 
 (h) Compliance and
Resolution. Borrower agrees that a failure to comply with Borrower’s obligations under this Addendum, or any other set of facts or circumstances where it has been asserted by any governmental regulatory agency that Agent, Lender and their
affiliates are not entitled to hold, or exercise any significant right with respect to, any securities issued to Lender by Borrower, will constitute a breach of the obligations of Borrower with respect to any of the SBIC Act requirements under the
financing agreements among Borrower, Agent and Lender. In the event of (i) a failure to comply with Borrower’s obligations under this Addendum; or (ii) an assertion by any governmental regulatory agency of a failure to comply with
Borrower’s obligations under this Addendum, then (x) Agent, Lender and Borrower will meet and resolve any such issue in good faith to the satisfaction of Borrower, Agent, Lender and 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
any governmental regulatory agency, and (y) upon request of Lender or Agent, Borrower will cooperate and assist with any assignment of the financing agreements among Hercules
Technology III, L.P. and Hercules Technology Growth Capital, Inc. required for compliance with the rules and regulations under the SBIC Act. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT A 

ADVANCE REQUEST 
  

			
	 To:   Agent:
		Date:             , 2013

 Hercules Technology Growth Capital, Inc. (the “Agent”) 

400 Hamilton Avenue, Suite 310 

Palo Alto, CA 94301 

Facsimile: 650-473-9194 

Attn: 
 ViewRay Incorporated
(“Borrower”) hereby requests from Agent and Hercules Technology III, L.P. (“Lender”) an Advance in the amount of Fifteen Million Dollars ($15,000,000) on
                    ,         (the “Advance Date”) pursuant to the Loan and Security
Agreement dated as of December [__], 2013 among Borrower, Agent and Lender (the “Agreement”). Capitalized words and other terms used but not otherwise defined herein are used with the same meanings as defined in the Agreement. 

Please: 
  

			
	 (a)    Issue a check payable to Borrower
		______
		
	 or
		
		
	 (b)    Wire Funds to Borrower’s account
		______

  

			
	 Bank:
		_____________________
	 Address:
		_____________________
			_____________________
	 ABA Number:
		_____________________
	 Account Number:
		_____________________
	 Account Name:
		_____________________

 Borrower represents to Agent and Lender that: 

(1) the representations and warranties set forth in the Agreement and in each other Loan Document are true and correct in all material
respects on and as of the Advance Date with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date; 

(2) no Event of Default has occurred and is continuing on the Advance Date, both immediately before and after giving effect to the advance
requested herein; and 
 (3) since December 31, 2012, no event has occurred that could reasonably be expected to have a Material
Adverse Effect. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Borrower understands and acknowledges that Agent has the right to review the financial
information supporting this representation and, based upon such review in its sole discretion, Lender may decline to fund the requested Advance. 

Executed as of [        ], 20[    ]. 

 

			
	BORROWER: VIEWRAY INCORPORATED
		
	SIGNATURE:	 	 
	TITLE:	 	 
	PRINT NAME:	 	 



  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT B 

SECURED TERM PROMISSORY NOTE 
  

			
	$15,000,000	  	Advance Date:          , 2013
		
		  	Maturity Date:              , 2017

 FOR VALUE RECEIVED, ViewRay Incorporated, a Delaware corporation, for itself and each of its Subsidiaries (the
“Borrower”) hereby promises to pay to the order of Hercules Technology III, L.P., a Delaware limited partnership or the holder of this Note (the “Lender”) at 400 Hamilton Avenue, Suite 310, Palo Alto, CA 94301 or
such other place of payment as the holder of this Secured Term Promissory Note (this “Promissory Note”) may specify from time to time in writing, in lawful money of the United States of America, the principal amount of Fifteen Million
Dollars ($15,000,000) or such other principal amount then outstanding, together with any accrued but unpaid interest thereon pursuant to the terms specified in the Loan Agreement (defined below). 

This Promissory Note is the Note referred to in, and is executed and delivered in connection with, that certain Loan and Security Agreement
dated December [        ], 2013, by and among Borrower, Hercules Technology Growth Capital, Inc., a Maryland corporation (the “Agent”) and the several banks and other financial institutions or
entities from time to time party thereto as lender (as the same may from time to time be amended, modified or supplemented in accordance with its terms, the “Loan Agreement”), and is entitled to the benefit and security of the Loan
Agreement and the other Loan Documents (as defined in the Loan Agreement), to which reference is made for a statement of all of the terms and conditions thereof. All payments shall be made in accordance with the Loan Agreement. All terms defined in
the Loan Agreement shall have the same definitions when used herein, unless otherwise defined herein. An Event of Default under the Loan Agreement shall constitute a default under this Promissory Note. 

Borrower waives presentment and demand for payment, notice of dishonor, protest and notice of protest under the UCC or any applicable law.
Borrower agrees to make all payments under this Promissory Note without setoff, recoupment or deduction and regardless of any counterclaim or defense. This Promissory Note has been negotiated and delivered to Lender and is payable in the State of
California. This Promissory Note shall be governed by and construed and enforced in accordance with, the laws of the State of California, excluding any conflicts of law rules or principles that would cause the application of the laws of any other
jurisdiction. 
 IN WITNESS WHEREOF, the undersigned has caused this Promissory Note to be duly executed as of the date first written above. 

 

			
	VIEWRAY INCORPORATED
		
	By:	 	 
	Name:	 	
	Title:	 	



  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT C 

NAME, LOCATIONS, AND OTHER INFORMATION FOR BORROWER 
  

			
	Name:		ViewRay Incorporated
		
	Type of Organization:		Corporation
		
	State of Organization:		Delaware
		
	Organizational Identification No.:		n/a
		
	Federal Tax Employer No.:		20-0818429
		
	Chief Executive Office Location:		 2 Thermo Fisher Way
 Bedford, Ohio
44146

		
	Other Locations:		2119 Landings Drive, Mountain View, CA 94043 (approximately 3800 square foot office sublease from Google Inc, expires in June 2014).


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT D 

BORROWER’S PATENTS, TRADEMARKS, COPYRIGHTS AND LICENSES 

Registered Intellectual Property 

Intellectual Property 
  

	(1)	Patents and patent applications: 

  

																	
	 Title
	  	Ctry	 	  	Patent/App. No.	 	  	Inventor(s)	 	  	Status	 
	 [****]
	  	 	[****]	  	  	 	[****]	  	  	 	[****]	  	  	 	[****]	  


  
 [***] Six pages in this document have
been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








	*	These patent applications are licensed to the Company by their owner, the University of Florida Research Foundation, Inc. pursuant to the Standard Exclusive License Agreement listed at Schedule 3.13(1).



	**	This application is jointly assigned to ViewRay and to Case Western Reserve University (CWRU) pursuant to the treatment of Joint Intellectual Property defined by the Sponsored Research Agreement between CWRU and
ViewRay. 

  

	(2)	Trademarks, service marks, trademark and service mark registrations and registration applications, trade names, trade name registrations, logos and trade dress 


 

							
	 Trademark
	  	 App Serial No
	  	 Classes
	  	 Status

	 Visibly Different
	  	86042072	  		  	Filed 8/19/2013
	 ViewRay (with design)
	  	86042168	  		  	Filed 8/19/2013
	 ViewRay (words only)
	  	86041992	  		  	Filed 8/19/2013
	 Chronicle Your Cure
	  	85583898	  	Classes 9, 10, 14	  	Allowed Oct. 30, 2012
	 Chronicle Your Care
	  	85583910	  	Classes 9, 10, 14	  	Allowed Oct. 30, 2012

  

	(3)	Copyright registrations: 

 The Company has not registered any copyrights at this time. 

 

	(4)	The Company owns all trade secrets and know how (if any) concerning the design, calibration and manufacture of the products currently under development by the Company including but not limited to the Renaissance TM MRI-Guided Radiotherapy System. The Company also owns all trade secrets, know-how (if any) and copyrights in the software developed for the products under development by the Company, which are
protected under copyright and by contract (as unpublished works embodying trade secrets). 

 The Company also owns all
intellectual property rights embodied in: (1) content at www.viewray.com website; and (2) internally developed brochures and promotional materials. 
  

	(5)	Licenses and other rights in Intellectual Property: 

 The Company has a license to the United States patent
application entitled [****] filed in the United States Patent Office on [****], as well as, to all divisionals, continuations, foreign counterparts, reissues, reexaminations and extensions of the application under the terms of the certain Standard
Exclusive License Agreement with Sublicensing Terms, dated as of December 15, 2004, by and between the Company and the University of Florida Research Foundation, Inc., as amended by Amendment No. 1, dated December 6, 2007 . 

The Company has an ownership interest in intellectual property, including a joint interest with CWRU in the United States patent application entitled
[****] filed in the United States Patent Office on [****], and assigned Serial Number [****], jointly developed under the Sponsored Research Agreement effective April 29, 2009 between Case Western Reserve University and
ViewRay Incorporated. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 The Company holds licenses to certain third party software under the following agreements: 

 

	 	(a)	[****] 

  

	 	(b)	[****] 

  

	 	(c)	[****] 

  

	 	(d)	[****] 

  

	 	(e)	Development and Supply Agreement dated May 28, 2008 between the Company and Siemens Aktiengesellschaft, Healthcare Sector as amended by Amendment No. 1, dated December 1, 2009, Amendment No. 2, dated
May 4, 2010 and Amendment No. 3, dated February 2, 2011, Contract Amendment No. 4 dated April 23, 2012, and Contract Amendment No. 5, dated May 30, 2012. 


The Company acquires all right title and interest in intellectual property rights embodied in certain deliverables that are developed for it by third party
vendors under its Master Services Agreements and Development and Supply Agreements. The Company also obtains licenses to use certain third party intellectual property rights that constitute “background intellectual property” necessary to
make use of the deliverables provided the Company pursuant to these agreements. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT E 

BORROWER’S DEPOSIT ACCOUNTS AND INVESTMENT ACCOUNTS 
  

					
	 Institution
	  	 Account No.
	  	Type of Account
	### #### ####### #########	  	##-####-####	  	##########
	### #### ####### #########	  	##-####-####	  	##########
	### #### ####### #########	  	##-####	  	##########


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT F 

COMPLIANCE CERTIFICATE 
 Hercules
Technology Growth Capital, Inc. (as “Agent”) 
 400 Hamilton Avenue, Suite 310 

Palo Alto, CA 94301 
 Reference is made to
that certain Loan and Security Agreement dated December [        ], 2013 (as amended from time to time, the “Loan Agreement”) by and among the several banks and other financial institutions or
entities from time to time party thereto (collectively, the “Lender”), Hercules Technology Growth Capital, Inc., as agent for the Lender (the “Agent”) and ViewRay Incorporated (the “Company”), as Borrower. All
capitalized terms not defined herein shall have the same meaning as defined in the Loan Agreement. 
 The undersigned is an Officer of the
Company, knowledgeable of all Company financial matters, and is authorized to provide certification of information regarding the Company; hereby certifies in [his/her] capacity as an officer and not in [his/her] individual capacity that: 

 

	 	1.	The undersigned certifies that the attached financial statements are prepared in accordance with GAAP (except for the absence of footnotes with respect to unaudited financial statements and subject to normal year-end
adjustments). 

  

	 	2.	[Except as set forth below,] [N]o Event of Default has occurred and is continuing on the date hereof. 


[Describe here or in a separate attachment any exceptions to paragraph 2 above by listing, in reasonable detail, the nature of the Event
of Default, the period during which it existed and the action that Borrower has taken or proposes to take with respect thereto.] 
  

					
	 REPORTING REQUIREMENT
		REQUIRED		 CHECK IF
 ATTACHED

	 Interim Financial Statements
		Monthly within 30 days		
	 Interim Financial Statements
		Quarterly within 30 days		
	 Audited Financial Statements
		FYE within 150 days		


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 
			
	Very Truly Yours,
	
	VIEWRAY INCORPORATED
		
	By:	 	 
	Name:	 	 
	Its:	 	 



  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT G 

FORM OF JOINDER AGREEMENT 

This Joinder Agreement (the “Joinder Agreement”) is made and dated as of [    ], 20[    ],
and is entered into by and between                     , a             
corporation (“Subsidiary”), and HERCULES TECHNOLOGY GROWTH CAPITAL, INC., a Maryland corporation (as “Agent”). 

RECITALS 
 A.
Subsidiary’s Affiliate, ViewRay Incorporated (“Company”) [has entered/desires to enter] into that certain Loan and Security Agreement dated December [    ], 2013, with the several banks and other financial
institutions or entities from time to time party thereto as lender (collectively, the “Lender”) and the Agent, as such agreement may be amended (the “Loan Agreement”), together with the other agreements executed and delivered in
connection therewith; 
 B. Subsidiary acknowledges and agrees that it will benefit both directly and indirectly from Company’s
execution of the Loan Agreement and the other agreements executed and delivered in connection therewith; 
 AGREEMENT 

NOW THEREFORE, Subsidiary and Agent agree as follows: 
  

	1.	The recitals set forth above are incorporated into and made part of this Joinder Agreement. Capitalized terms not defined herein shall have the meaning provided in the Loan Agreement. 


 

	2.	By signing this Joinder Agreement, Subsidiary shall be bound by the terms and conditions of the Loan Agreement the same as if it were the Borrower (as defined in the Loan Agreement) under the Loan Agreement, mutatis
mutandis, provided however, that (a) with respect to (i) Section 5.1 of the Loan Agreement, Subsidiary represents that it is an entity duly organized, legally existing and in good standing under the laws of [    ],
(b) neither Agent nor Lender shall have any duties, responsibilities or obligations to Subsidiary arising under or related to the Loan Agreement or the other agreements executed and delivered in connection therewith, (c) that if Subsidiary
is covered by Company’s insurance, Subsidiary shall not be required to maintain separate insurance or comply with the provisions of Sections 6.1 and 6.2 of the Loan Agreement, and (d) that as long as Company satisfies the requirements
of Section 7.1 of the Loan Agreement, Subsidiary shall not have to provide Agent separate Financial Statements. To the extent that Agent or Lender has any duties, responsibilities or obligations arising under or related to the Loan Agreement or
the other agreements executed and delivered in connection therewith, those duties, responsibilities or obligations shall flow only to Company and not to Subsidiary or any other Person or entity. By way of example (and not an exclusive list):
(i) Agent’s providing notice to Company in accordance with the Loan Agreement or as otherwise agreed among Company, Agent and Lender shall be deemed provided to Subsidiary; (ii) a Lender’s providing an Advance to Company shall be
deemed an Advance to Subsidiary; and (iii) Subsidiary shall have no right to request an Advance or make any other demand on Lender. 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








	3.	Subsidiary agrees not to certificate its equity securities without Agent’s prior written consent, which consent may be conditioned on the delivery of such equity securities to Agent in order to perfect Agent’s
security interest in such equity securities. 

  

	4.	Subsidiary acknowledges that it benefits, both directly and indirectly, from the Loan Agreement, and hereby waives, for itself and on behalf on any and all successors in interest (including without limitation any
assignee for the benefit of creditors, receiver, bankruptcy trustee or itself as debtor-in-possession under any bankruptcy proceeding) to the fullest extent provided by law, any and all claims, rights or defenses to the enforcement of this Joinder
Agreement on the basis that (a) it failed to receive adequate consideration for the execution and delivery of this Joinder Agreement or (b) its obligations under this Joinder Agreement are avoidable as a fraudulent conveyance.


 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 [SIGNATURE PAGE TO JOINDER AGREEMENT] 

SUBSIDIARY: 
  

 

			
		
	                      By:	 	 
	                      Name:	 	
	                      Title:	 	

  

			
	                      Address:
		
	                      Telephone:	 	 
	                      Facsimile:	 	 

 AGENT: 
 HERCULES TECHNOLOGY
GROWTH CAPITAL, INC. 
  

			
		
	                      By:	 	 
	                      Name:	 	 
	                      Title:	 	 

 Address: 

400 Hamilton Ave., Suite 310 

Palo Alto, CA 94301 

Facsimile: 650-473-9194 

Telephone: 650-289-3060 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 EXHIBIT H 

ACH DEBIT AUTHORIZATION AGREEMENT 

Hercules Technology Growth Capital, Inc., as Agent 
 400 Hamilton
Avenue, Suite 310 
 Palo Alto, CA 94301 

Re: Loan and Security Agreement dated December [ ], 2013 between ViewRay Incorporated (“Borrower”), the several banks and
other financial institutions or entities from time to time parties thereto (collectively, referred to as “Lender”), and Hercules Technology Growth Capital, Inc., as agent for the Lender (“Company”) (the “Agreement”)

 In connection with the above referenced Agreement, the Borrower hereby authorizes the Company to initiate debit entries for the periodic payments of
principal and interest due under the Agreement to the Borrower’s account indicated below. The Borrower authorizes the depository institution named below to debit to such account with respect to such payments of principal and interest. 

 

			
	DEPOSITORY NAME		BRANCH
		
	CITY		STATE AND ZIP CODE
		
	TRANSIT/ABA NUMBER		ACCOUNT NUMBER

 This authority will remain in full force and effect so long as any amounts are due under the Agreement. 

 

			
	 
	(Borrower)(Please Print)
		
	By:		 
	Date:		 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 1 

Subsidiaries 
 None. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 1.1 

COMMITMENTS 
  

					
	 LENDER
	  	TERM
COMMITMENT	 
	 Hercules Technology III, L.P.
	  	$	15,000,000	  
	 TOTAL COMMITMENTS
	  	$	15,000,000	  


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 1.2 

Magnet Collateral 
 See attached 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 SCHEDULE 1 

The Magnet (as defined in the Loan Agreement) is more completely and accurately described below, and principally consists of the following:

  

	(1)	The Magnet system 

 The Magnet is an actively shielded 0.35 tesla [****]
bore magnet system with [****] split. The Magnet is a complete superconducting magnet system intended primarily for large field of view MRI imaging applications in conjunction with radiotherapy. 

The Magnet system essentially consists of a highly homogenous superconducting magnet wound in a split pair configuration. The two
halves are housed in [****] that are supported on a [****] between the two halves. Each [****] requires a [****] and facilitate [****]. The two [****] are separated by a [****]. 

[****] is accomplished using [****] located in the gradient coils. 

The Magnet system is complemented with the supply of [****] and an emergency discharge unit. 

 

	(2)	The Magnet 

 The Magnet is wound from [****] with a [****] to superconductor. The
windings are placed on [****] and then [****]. 
 The field homogeneity is defined over a [****]. Inevitable winding
tolerances and small amounts of environmental influence will [****]. Corrections for these distortions are made in the first instance by [****], and additionally a [****]. 

The main magnet coils are fully protected from accidental damage due to a [****] located within the [****]. 

In the event of the need to activate an emergency discharge of the Magnet, a [****] is incorporated within the windings. 

 

	(3)	The [****] 

 Each half of the [****] consists of a [****]
which is surrounded by [****] by the [****] of a [****]. The second state of the [****] in the [****] and so eliminates the loss of any [****] due to [****]. The complete assembly is contained in a
[****]. The outer [****] is fitted with a [****] located on [****]. The [****] provides access to the [****] for the [****]. A second [****]. The outer vessel is [****] with a
[****] constructed from [****]. 
 Each [****] contains in total approximately [****] of which approximately [****] is
above the [****]. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 A [****] is incorporated into each [****] and the associated electronics provide [****] and a
[****]. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 2 

 

			
	 Vendor
	  	 Description

	Dell	  	Dell D630 Laptop with 160GB Hard Drive and 4GB of RAM, 2.6Ghz Dual Core CPU, 24” LCD Monitor, USB Keyboard and Mouse, and Docking Station with Monitor Stand for H/W QA Engineer (Danny Glenboski).
		
	Dell	  	Dell M4300 Laptop with 160GB Hard Drive and 4GB of RAM, 2.6Ghz Dual Core CPU, 24” LCD Monitor, USB Keyboard and Mouse, and Docking Station with Monitor Stand for Director of Clinical Science and RSO (Daryoush
Bagheri).
		
	Dell	  	Dell D630 Laptop with 160GB Hard Drive and 4GB of RAM, 2.6Ghz Dual Core CPU, 24” LCD Monitor, USB Keyboard and Mouse, and Docking Station with Monitor Stand for MRI Systems Engineer (Bela Vajko).
		
	Dell	  	Dell T7400 High Performance Workstation with 2 500GB Hard Drives and 64GB of RAM, Quad Core, 3.0Ghz Processor, 24” LCD Monitor, USB Keyboard and Mouse for High Performance Software Development.
		
	Dell	  	Dell D630 Laptop with 160GB Hard Drive and 4GB of RAM, 6Ghz Dual Core CPU.
		
	Dell	  	3 Dell D830 Laptop with 160GB Hard Drive and 4GB of RAM, 2.6Ghz Dual Core CPU, 24” LCD Monitor, USB Keyboard and Mouse, and Docking Station with Monitor Stand for S/W Engineer (Meredith Stone), HPC Engineer (Tim Gacek), and S/W
QA Engineer (Sireesha Gogineni).
		
	Dell	  	2 Dell T5400 Workstation with 160GB Hard Drive, 4GB or RAM, 3.00Ghz Quad Core CPU, 24” Monitor, USB Keyboard and Mouse for Mechanical Designer (Jerry Rybar) and MRI Technician (Brian Cohen).
		
	Dell	  	12 4GB Memory Modules for Dell Precision High Performance Workstation for High Performance Software Development.
		
	Dell	  	4 Dell D830 Laptop with 160GB Hard Drive and 4GB of RAM, 2.10Ghz Dual Core CPU, 24” LCD Monitor, USB Keyboard and Mouse, and Docking Station with Monitor Stand for S/W Engineer (Jeffrey Adair), S/W Engineer (Matt Moran), Sr.
S/W Engineer (Jeff Paynowski) and Scientist (Qingguo Zeng).
		
	Office Designs	  	119 Office Chairs
		
	Office Furniture Heaven	  	Conference Tables/Credenza/Desks/Electronic Whiteboards
		
	Office Furniture Heaven	  	File Cabinets / Chairs
		
	Working Environments	  	45 KI Cubicles
		
	Working Environments	  	10 Knoll Cubicles


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule lA 

Permitted Indebtedness 
  

	1.	All outstanding obligations owing under that Loan Agreement dated as of December 15, 2008 by and between ViewRay Incorporated, as borrower, and County of Cuyahoga, Ohio, as lender. This is a term note and the
principal amount outstanding as of the Closing Date is $240,000. 

  

	2.	Irrevocable Standby Letter of Credit No. SCL015925, by and between the Company, as Applicant, and the Ohio Department of Health, as Beneficiary, dated as of February 8, 2010, for $102,545 including the following
exhibits: 

  

	 	(a)	Security Agreement, dated February 3, 2010 between the Company and PNC Bank, National Association 

  

	 	(b)	Certified Board Resolutions for Credit Extensions and Security, dated February 3, 2010 made to PNC Bank, National Association by James F. Dempsey, on behalf of the Company 


 

	3.	Irrevocable Standby Letter of Credit No. 12503152-00-000, by and between the Company, as Applicant, and Barnes Jewish Hospital as Beneficiary, dated as of April 8, 2011, for $350,000 including the related
Security Agreement, dated April 5, 2011 between the Company and PNC Bank, National Association. 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 1B 

Permitted Investments 
 None 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 1C 

Permitted Liens 
  

	1.	Liens granted in favor of the County of Cuyahoga, Ohio pursuant to the Security Agreement dated as of December 15, 2008 to secure the obligations described in paragraph 1 on Schedule lA and perfected by the UCC-1
financing statement number 84253678 filed with the Delaware Secretary of State 

  

	2.	Loan Agreement, by and between the Company, as Borrower, and County of Cuyahoga, Ohio, as Lender, dated as of December 15, 2008, for an $800,000 Loan, of which $240,000 in principal amount is currently outstanding,
for Renovation of the premises at 2 Thermo Fisher Way, Village of Oakwood, Cuyahoga County, Ohio 44146, including the following exhibits: 

  

	 	(a)	Security Agreement, dated December 15, 2008 between the Company and the County of Cuyahoga, Ohio 

  

	 	(b)	Note in the amount of $800,000, dated December 15 2008 between the Company and the County of Cuyahoga, Ohio 

  

	 	(c)	Amendment and Ratification Agreement, dated December 15, 2008 between the Company and the County of Cuyahoga, Ohio 

  

	 	(d)	UCC Financing Statement, filed December 22, 2008 between the Company and the County of Cuyahoga, Ohio 

  

	3.	Irrevocable Standby Letter of Credit No. SCL015925, by and between the Company, as Applicant, and the Ohio Department of Health, as Beneficiary, dated as of February 8, 2010, for $102,545 including the following
exhibits: 

  

	 	(a)	Security Agreement, dated February 3, 2010 between the Company and PNC Bank, National Association 

  

	 	(b)	Certified Board Resolutions for Credit Extensions and Security, dated February 3, 2010 made to PNC Bank, National Association by James F. Dempsey, on behalf of the Company 


 

	4.	Irrevocable Standby Letter of Credit No. 12503152-00-000, by and between the Company, as Applicant, and Barnes Jewish Hospital as Beneficiary, dated as of April 8, 2011, for $350,000 including the related
Security Agreement, dated April 5, 2011 between the Company and PNC Bank, National Association. 


  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.3 

Consents 
 None 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.5 

Material Litigation 
 None 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.8 

Taxes 
 None 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.9 

Intellectual Property Claims 
 None. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.10 

Intellectual Property Rights 
 See Exhibit D 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.11 

Borrower Products 
 None. 

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 







 Schedule 5.14 

Capitalization of Borrower 
  

																	
	 Holders:
	 	Common Stock Held	 	 	Series A Preferred
Stock Held	 	 	Series B Preferred Stock
Held	 	 	Series C Preferred
Stock Held	 
	 OrbiMed Private Investments III, LP
	 				 				 	 	14,868,504	  	 	 	1,155,661	  
	 OrbiMed Associates III, LP
	 				 				 	 	141,606	  	 	 	11,006	  
	 Beacon Bioventures Fund II Limited Partnership
	 				 				 	 	15,010,110	  	 	 	1,166,667	  
	 Aisling Capital II, LP
	 				 				 	 	15,010,110	  	 	 	1,166,667	  
	 Kearny Venture Partners, L.P.
	 				 				 	 	4,202,870	  	 	 	326,669	  
	 Kearny Venture Partners Entrepreneurs’ Fund, L.P.
	 				 				 	 	85,721	  	 	 	6,662	  
	 Thomas Weisel Healthcare Venture Partners, L.P.
	 				 				 	 	4,288,597	  	 	 	333,332	  
	 Royal Seal Holding Co., Limited
	 				 				 				 	 	2,083,333	  
	 James F. Dempsey, Ph.D
	 	 	570,000 *	  	 				 				 			
	 University of Florida Research Foundation
	 	 	82,017	  	 				 				 			
	 Mark Gold
	 	 	6,600	  	 				 	 	1,225	  	 			
	 MJSK, Ltd.
	 				 	 	13,000	  	 	 	118,923	  	 			
	 JMSK Ltd.
	 				 	 	13,000	  	 	 	54,619	  	 			
	 [****]
	 	 	[****	] 	 	 	[****	] 	 	 	[****	] 	 	 	[****	] 

  

	*	Includes 125,000 options to purchase common stock, which were converted from previously held restricted stock for each holder indicated. 


  
 [***] Five pages in this document have
been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 








																									
	 Name of Optionee
	  	Shares
Granted	 	 	Grant
Type	 	 	Grant Date	 	 	Shares
Forfeited	 	 	Shares
Exercised	 	 	Outstanding	 
	 James Dempsey
	  	 	183,370	  	 	 	ISO	  	 	 	6/17/2008	  	 				 				 	 	183,370	  
	 Peter Roemer
	  	 	11,000	  	 	 	ISO	  	 	 	12/8/2008	  	 				 				 	 	11,000	  
	 Mark Gold
	  	 	11,000	  	 	 	ISO	  	 	 	12/8/2008	  	 				 				 	 	11,000	  
	 James Dempsey
	  	 	150,490	  	 	 	ISO	  	 	 	6/29/2010	  	 				 				 	 	150,490	  
	 Mark Gold
	  	 	9,028	  	 	 	ISO	  	 	 	6/29/2010	  	 				 				 	 	9,028	  
	 Peter Roemer
	  	 	9,028	  	 	 	ISO	  	 	 	6/29/2010	  	 				 				 	 	9,028	  
	 James Dempsey
	  	 	481,637	  	 	 	ISO	  	 	 	6/29/2010	  	 				 				 	 	481,637	  
	 Mark Gold
	  	 	11,392	  	 	 	ISO	  	 	 	6/29/2010	  	 				 				 	 	11,392	  
	 Peter Roemer
	  	 	11,392	  	 	 	ISO	  	 	 	6/29/2010	  	 				 				 	 	11,392	  
	 David Chandler
	  	 	314,199	  	 	 	ISO	  	 	 	2/4/2011	  	 				 				 	 	314,199	  
	 Michael Brandt
	  	 	215,000	  	 	 	ISO	  	 	 	12/1/2011	  	 				 				 	 	215,000	  
	 James Dempsey
	  	 	154,162	  	 	 	ISO	  	 	 	3/1/2012	  	 				 				 	 	154,162	  
	 David Chandler
	  	 	59,397	  	 	 	ISO	  	 	 	3/1/2012	  	 				 				 	 	59,397	  
	 Michael Brandt
	  	 	40,644	  	 	 	ISO	  	 	 	3/1/2012	  	 				 				 	 	40,644	  
	 Mark Gold
	  	 	5,940	  	 	 	ISO	  	 	 	3/1/2012	  	 				 				 	 	5,940	  
	 Peter Roemer
	  	 	5,940	  	 	 	ISO	  	 	 	3/1/2012	  	 				 				 	 	5,940	  
	 Chris Raanes
	  	 	2,400,090	  	 	 	ISO	  	 	 	2/7/2013	  	 				 				 	 	2,400,090	  
	 [****]
	  	 	[****	] 	 	 	[****	] 	 	 	[****	] 	 	 	[****	] 	 	 	[****	] 	 	 	[****	] 


  
 [***] Seven pages in this document have
been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.